Pyrazole compound

ABSTRACT

A pyrazole compound of formula (a):  
                 
 
wherein R 1  represents C1-C4 alkyl or trifluoromethyl, R 2  represents C1-C4 alkyl, R 3  represents hydrogen or C1-C6 alkyl; R 4  represents halogen and so on, m represents 0 to 4 integer; R 5  represents halogen and so on, n represents 0 to 4 integer; R 6  and R 7  are same or different and represents hydrogen, halogen or methyl; X represents oxygen or R 8 O—N; R 8  represents hydrogen, C1-C6 alkyl and the like; 
has an excellent controlling activity against noxious arthropods.

TECHNICAL FIELD

The present invention relates to pyrazole compounds, intermediate compounds thereof and a control method of noxious arthropods by using them.

BACKGROUND ART

A certain type of pyrazole compounds is known as an active ingredient of pesticides and acaricides. See U.S. Pat. No. 4,843,068.

However, noxious arthropods controling activity of these pyrazole compounds is not enough in some cases, and therefore a novel compound having a noxious arthropods controlling activity is desired.

DISCLOSURE OF INVENTION

The present invention provides a pyrazole compound (hereinafter, referred as the compound of the present invention) of formula (a):

wherein R¹ represents C1-C4 alkyl or trifluoromethyl, R² represents C1-C4 alkyl, R³ represents hydrogen or C1-C6 alkyl; R⁴ represents halogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkyl or C1-C3 haloalkoxy, m represents 0 to 4 integer, each of R⁴s is same or different when m is 2 to 4 integer; R⁵ represents halogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkyl or C1-C3 haloalkoxy, n represents 0 to 4 integer, each of R⁵s is same or different when n is 2 to 4 integer; R⁶ and R⁷ are same or different and represents hydrogen, halogen or methyl, X represents oxygen or R⁸O—N; R⁸ represents hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or benzyl (wherein the benzyl may be substituted with halogen, C1-C4 alkyl, C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoromethoxy);

-   a noxious arthropods controlling composition comprising the compound     of the present invention; and a method for controlling noxious     arthropods characterized by applying an effective amount of the     compound of the present invention to noxious arthropods or habitat     of noxious arthropods.

Furthermore, the present invention also provides a compound of formula (b):

wherein R¹ represents C1-C4 alkyl or trifluoromethyl, R² represents C1-C4 alkyl, R³ represents hydrogen or C1-C6 alkyl; R⁴ represents halogen, C1-C3 alkyl, C1-C3 alkoxy or trifluoromethyl, m represents 0 to 4 integer, each of R⁴s is same or different when m is 2 to 4 integer; R⁵ represents halogen, C1-C3 alkyl, C1-C3 alkoxy or trifluoromethyl, n represents 0 to 4 integer, each of R⁵s is same or different when n is 2 to 4 integer; X represents oxygen or by R⁸O—N; R⁸ represents hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or benzyl (wherein the benzyl may be substituted with halogen, C1-C4 alkyl, C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro methoxy); which is useful as an intermediate of the compound of the present invention.

In the compound of the present invention, each substituent represented by R¹, R², R³, R⁴, R⁵, R⁶, R⁷ or R⁸ is exemplified the following substituents concretely.

The C1-C4 alkyl represented by R¹ is methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl and tert-butyl.

The C1-C4 alkyl represented by R² is methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl and tert-butyl.

The C1-C6 alkyl represented by R³ includes methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, 3-methylbutyl, 2,2-dimethylpropyl, 1,1-dimethylpropyl, 1-ethylpropyl, hexyl, 5-methylpentyl, 2-ethylbutyl, 3-methylpentyl and 1,3-dimethylbutyl.

The halogen represented by R⁴ and R⁵ is a fluorine, chlorine, bromine and iodine;

-   the C1-C3 alkyl includes methyl, ethyl, propyl and isopropyl; -   the C1-C3 alkoxy includes methoxy, ethoxy, propoxy and isopropoxy; -   the C1-C3 haloalkyl includes trifluoromethyl, 2-fluoroethyl,     2,2,2-trifluoroethyl, 3,3,3-trifluoropropyl, 2-chloroethyl and     3-bromopropyl; -   the C1-C3 haloalkoxy includes trifluoroalkoxy, 2,2,2-trifluoroethoxy     and 3,3,3-trifluoropropoxy.

The halogen represented by R⁶ is a fluorine, chlorine, bromine and iodine.

The halogen represented by R⁷ is a fluorine, chlorine, bromine and iodine.

The C1-C6 alkyl represented by R⁸ includes methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, neopentyl, tert-pentyl,

-   1-methylbutyl, 1,2-dimethylpropyl and hexyl; -   the C1-C6 haloalkyl includes fluoromethyl, 2-fluoroethyl,     2,2,2-trifluoroethyl, 3,3,3-trifluoropropyl, 4,4,4-trifluorobutyl,     5,5,5-trifluoropentyl, 2-chloroethyl, 3-chloropropyl, 3-bromopropyl,     4-chlorobutyl, 4-bromobutyl, 4-chloropentyl and 4-bromopentyl; -   the C3-C6 alkenyl includes allyl, 2-methyl-2-propenyl,     3-methyl-2-butenyl, 2-butenyl, 3-butenyl, 2-pentenyl, 3-pentenyl,     2-hexenyl and 3-hexenyl; -   the C3-C6 haloalkenyl includes 3-chloro-2-propenyl,     3,3-dichloro-2-propenyl, 3-bromo-2-propenyl, 3,3-dibromo-2-propenyl,     2-chloro-2-propenyl, 2-bromo-2-propenyl, 2-fluoro-2-propenyl,     2,3-dichloro-2-propenyl, 2,3-dibromo-2-propenyl, 3-chloro-2-butenyl,     3-chloro-4, 4, 4-trifluoro-2-butenyl, 4-chloro-2-butenyl, -   butenyl, 4-bromo-2-butenyl and 2,3,3-trifluoro-2-propenyl; the C3-C6     alkynyl includes 2-propynyl, 2-butynyl, 2-pentynyl, 3-butynyl and     1-methyl-2-propynyl; -   the C3-C6 haloalkynyl includes 3-chloro-2-propynyl,     4-chloro-3-butynyl, 5-chloro-4-pentynyl, 6-chloro-5-hexynyl,     3-bromo-2-propynyl, 4-bromo-3-butynyl, 5-bromo-4-pentynyl and     6-bromo-5-hexynyl; -   the C2-C5 cyano alkyl includes cyanomethyl, 2-cyanoethyl,     3-cyanopropyl and 4-cyanobutyl; -   the benzyl optionally substituted with halogen, C1-C4 alkyl, C1-C4     alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoromethoxy     includes benzyl, 2-fluorobenzyl, 3-fluorobenzyl, 4-fluorobenzyl,     2-chlorobenzyl, 3-chlorobenzyl, 4-chlorobenzyl, 2-bromobenzyl,     3-bromobenzyl, 4-bromobenzyl, 2,3-dichlorobenzyl,     3,5-dichlorobenzyl, 2,4-dichlorobenzyl, 2-methylbenzyl,     3-methylbenzyl, 4-methylbenzyl, 2,3-dimethylbenzyl,     3,5-dimethylbenzyl, 2,4-dimethylbenzyl, 2-methoxybenzyl,     3-methoxybenzyl, 4-methoxybenzyl, 2,3-dimethoxybenzyl,     3,5-dimethoxybenzyl, 2,4-dimethoxybenzyl, 4-methoxycarbonylbenzyl,     4-ethoxycarbonylbenzyl, 4-propoxycarbonylbenzyl,     4-trifluoromethylbenzyl and 4-trifluoromethoxybenzyl.

The embodiments of the compound of the present invention are exemplified as follows:

-   the pyrazole compound wherein R¹ is methyl in the formula (a); -   the pyrazole compound wherein R¹ is ethyl in~the formula (a); -   the pyrazole compound wherein R¹ is trifluoromethyl in the formula     (a); -   the pyrazole compound wherein R² is methyl in the formula (a); -   the pyrazole compound wherein R³ is hydrogen in the formula (a); -   the pyrazole compound wherein R³ is methyl in the formula (a); -   the pyrazole compound wherein m is 0 in the formula (a); -   the pyrazole compound wherein n is 0 in the formula (a); -   the pyrazole compound wherein R⁶ is chlorine in the formula (a); -   the pyrazole compound wherein R⁶ and R⁷ are chlorine in the formula     (a); -   the pyrazole compound wherein R¹ is methyl, and R² is methyl in the     formula (a); -   the pyrazole compound wherein R¹ is ethyl, and R² is methyl in the     formula (a); -   the pyrazole compound wherein R¹ is trifluoromethyl, and R² is     methyl in the formula (a); -   the pyrazole compound wherein R¹ is methyl, and R⁶ is chlorine in     the formula (a); -   the pyrazole compound wherein R¹ is ethyl, and R⁶ is chlorine in the     formula (a); -   the pyrazole compound wherein R¹ is trifluoromethyl, and R⁶ is     chlorine in the formula (a); -   the pyrazole compound wherein R¹ is methyl, and R⁶ and R⁷ are     chlorine in the formula (a); -   the pyrazole compound wherein R¹ is ethyl, and R⁶ and R⁷ are     chlorine in the formula (a); -   the pyrazole compound wherein R¹ is trifluoromethyl, and R⁶ and R⁷     are chlorine in the formula (a); -   the pyrazole compound wherein R¹ is methyl, R² is methyl, and R⁶ is     chlorine in the formula (a); -   the pyrazole compound wherein R¹ is ethyl, R² is methyl, and R⁶ is     chlorine in the formula (a); -   the pyrazole compound wherein R¹ is trifluoromethyl, R² is methyl,     and R⁶ is chlorine in the formula (a); -   the pyrazole compound wherein R¹ is methyl, R² is methyl, and R⁶ and     R⁷ are chlorine in the formula (a); -   the pyrazole compound wherein R¹ is ethyl, R² is methyl, and R⁶ and     R⁷ are chlorine in the formula (a); -   the pyrazole compound wherein R¹ is trifluoromethyl, R² is methyl,     and R⁶ and R⁷ are chlorine in the formula (a); -   the pyrazole compound wherein R¹ is methyl, R² is methyl, R³ is     hydrogen, and R⁶ and R⁷ are chlorine in the formula (a); -   the pyrazole compound wherein R¹ is ethyl, R² is methyl, R³ is     hydrogen atom, and R⁶ and R⁷ are chlorine in the formula (a); -   the pyrazole compound wherein R¹ is trifluoromethyl, R² is methyl,     R³ is hydrogen atom, and R⁶ and R⁷ are chlorine in the formula (a); -   the pyrazole compound wherein R¹ is methyl, R² is methyl, R³ is     methyl, and R⁶ and R⁷ are chlorine in the formula (a); -   the pyrazole compound wherein R¹ is ethyl, R² is methyl, R³ is     methyl, and R⁶ and R⁷ are chlorine in the formula (a); -   the pyrazole compound wherein R¹ is trifluoromethyl, R² is methyl,     R³ is methyl, and R⁶ and R⁷ are chlorine in the formula (a); -   the pyrazole compound wherein R¹ is methyl, R² is methyl, m is 0,     and n is 0 in the formula (a); -   the pyrazole compound wherein R¹ is ethyl, R² is methyl, m is 0, and     n is 0 in the formula (a); -   the pyrazole compound wherein R¹ is trifluoromethyl, R² is methyl, m     is 0, and n is 0 in the formula (a); -   the pyrazole compound wherein R¹ is methyl, R² is methyl, m is 0, n     is 0, and R⁶ is chlorine in the formula (a); -   the pyrazole compound wherein R¹ is ethyl, R² is methyl, m is 0, n     is 0, and R⁶ is chlorine in the formula (a); -   the pyrazole compound wherein R¹ is trifluoromethyl, R² is methyl, m     is 0, n is 0, and R⁶ is chlorine in the formula (a); -   the pyrazole compound wherein R² is methyl, and R⁶ is chlorine in     the formula (a); -   the pyrazole compound wherein R² is methyl, and R⁶ and R⁷ are     chlorine in the formula (a); -   the pyrazole compound wherein R² is methyl, m is 0, and n is 0 in     the formula (a); -   the pyrazole compound wherein R² is methyl, m is 0, n is 0, and R⁶     is chlorine in the formula (a); -   the pyrazole compound wherein R² is methyl, m is 0, n is 0, and R⁶     and R⁷ are chlorine in the formula (a); -   the pyrazole compound wherein m is 0, and n is 0 in the formula (a);     the pyrazole compound wherein m is 0, n is 0, and R⁶ is chlorine in     the formula (a); -   the pyrazole compound wherein m is 0, and n is 0, and R⁶ and R⁷ are     chlorine in the formula (a); -   the pyrazole compound wherein R³ is hydrogen in the formula (a); -   the pyrazole compound wherein R³ is C1-C6 alkyl in the formula (a); -   the pyrazole compound wherein X is R⁸O—N; R⁸ is hydrogen, C1-C6     alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6     alkynyl, C3-C6 haloalkynyl, C2-C5 cyanoalkyl or benzyl (wherein the     benzyl may be substituted with halogen, C1-C4 alkyl, C1-C4 alkoxy,     C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoromethoxy) in the     formula (a); -   the pyrazole compound wherein X is R⁸O—N, and R⁸ is hydrogen, C1-C6     alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6     alkynyl, C3-C6 haloalkynyl or C2-C5 cyanoalkyl in the formula (a); -   the pyrazole compound wherein X is R⁸O—N, and R⁸ is benzyl (wherein     the benzyl may be substituted with halogen, C1-C4 alkyl, C1-C4     alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoromethoxy)     in the formula (a); -   the pyrazole compound wherein X is oxygen in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, and R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyanoalkyl or     benzyl (wherein the benzyl may be substituted with halogen, C1-C4     alkyl, C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or     trifluoromethoxy) in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, and R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl or C2-C5 cyanoalkyl in     the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, and R⁸ is     benzyl (wherein the benzyl may be substituted with halogen, C1-C4     alkyl, C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or     trifluoromethoxy) in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, and X is oxygen in the     formula (a); -   the pyrazole compound wherein R³ is a hydrogen atom, X is R⁸O—N, R⁸     is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyanoalkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or     trifluoromethoxy), R⁴ and R⁵ are halogen, C1-C3 alkyl, C1-C3 alkoxy     or trifluoromethyl, and m and n are 0 to 2 integer in the formula     (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl or C2-C5 cyanoalkyl,     R⁴ and R⁵ are halogen, C1-C3 alkyl, C1-C3 alkoxy or trifluoromethyl,     and m and n are 0 to 2 integer in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or     trifluoromethoxy), R⁴ and R⁵ are halogen, C1-C3 alkyl, C1-C3 alkoxy     or trifluoromethyl, and m and n are 0 to 2 integer in the formula     (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, and R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl or C2-C5 cyanoalkyl,     and R⁴ and R⁵ are hydrogen in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is oxygen, and R⁴     and R⁵ are halogen, C1-C3 alkyl, C1-C3 alkoxy or trifluoromethyl, m     and n are 0 to 2 integer in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, R⁶ is halogen, X is     R⁸O—N, and R⁸ is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6     alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5     cyanoalkyl or benzyl (the benzyl may be substituted with halogen,     C1-C4 alkyl, C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or     trifluoromethoxy) in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, R⁶ is halogen, X is     R⁸O—N, and R⁸ is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6     alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl or     C2-C5 cyanoalkyl in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, R⁶ is halogen, X is     R⁸O—N, and R⁸ is benzyl (the benzyl may be substituted with halogen,     C1-C4 alkyl, C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or     trifluoromethoxy) in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, R⁶ is halogen, and X     is oxygen in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, R⁶ and R⁷ are halogen,     X is R⁸O—N, and R⁸ is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6     alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5     cyanoalkyl or benzyl (the benzyl may be substituted with halogen,     C1-C4 alkyl, C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or     trifluoro methoxy) in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, R⁶ and R⁷ are halogen,     X is R⁸O—N, and R⁸ is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6     alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl or     C2-C5 cyanoalkyl in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, R⁶ and R⁷ are halogen,     X is R⁸O—N, and R⁸ is benzyl (the benzyl may be substituted with     halogen, a C1-C4 alkyl, C1-C4 alkoxy, C2-C5 alkoxycarbonyl,     trifluoromethyl or trifluoro methoxy) in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, R⁶ and R⁷ are halogen,     and X is oxygen in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), and R¹ is methyl in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), and R¹ is ethyl in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), and R¹ is trifluoromethyl in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, a C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), and R² is methyl in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), and R³ is hydrogen in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), and R³ is methyl in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), and m is 0 in the formula (a); -   the pyrazole compound wherein n is 0 in the formula (a); the     pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), and R⁶ is chlorine in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, a C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), and R⁶ and R⁷ are chlorine in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), R¹ is methyl, and R² is methyl in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), R¹ is ethyl, and R² is methyl in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano-alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), R¹ is trifluoromethyl, and R² is methyl in the formula     (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), R¹ is methyl, R² is methyl, R³ is hydrogen, and R⁶ and R⁷     are chlorine in the formula (a); -   the pyrazole compound wherein R¹ is ethyl, R² is methyl, R³ is     hydrogen, and R⁶ and R⁷ are chlorine in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), R¹ is trifluoromethyl, R² is methyl, R³ is hydrogen, and     R⁶ and R⁷ are chlorine in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), R¹ is methyl, R² is methyl, R³ is methyl, and R⁶ and R⁷     are chlorine in the formula (a); -   the pyrazole compound wherein R¹ is ethyl, R² is methyl, R³ is     methyl, and R⁶ and R⁷ are chlorine in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), R¹ is trifluoromethyl, R² is methyl, R³ is methyl, and R⁶     and R⁷ are chlorine in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), m is 0, and n is 0 in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), m is 0, n is 0, and R⁶ is chlorine in the formula (a); -   the pyrazole compound wherein R³ is hydrogen, X is R⁸O—N, R⁸ is     hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6     haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or     benzyl (the benzyl may be substituted with halogen, C1-C4 alkyl,     C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro     methoxy), m is 0, n is 0, and R⁶ and R⁷ are chlorine in the formula     (a).

The compound of the present invention can be produced by the following method such as Production Method 1 to Production Method 4.

Production Method 1

The compound of the present invention is produced by making a compound of formula (b):

wherein R¹, R², R^(3,) R⁴, R⁵, X, m and n have the same meaning as described above;

-   react with a compound of formula (e):     L-CH₂CH═C(R⁶)(R⁷)   (e)     wherein R⁶ and R⁷ have the same meaning as described above, and L     represents halogen (such as chlorine or bromine),     methanesulfonyloxy, benzensulfonyloxy or toluenesulfonyloxy.

The reaction is carried out in the presence of a base usually in a solvent. The reaction temperature is usually −78 to 150° C., and the reaction period is 0.1 to 24 hours.

Examples of the solvent used for the reaction include ketones such as acetone, methyl ethyl ketone and so on; aromatic hydrocarbons such as toluene, xylene and so on; aliphatic hydrocarbons such as hexane, heptane and so on; ethers such as diethyl ether, tetrahydrofuran, 1,4-dioxane, 1,2-dimethoxyethane, 1,2-diethoxyethane and so on; halogenated hydrocarbons such as dichloromethane, chloroform, 1,2-dichloroethane, chlorobenzene, dichlorobenzene and so on; amides such as N,N-dimethylformamide, N,N-diethylacetamide and so on; nitrites such as acetonitrile and so on; dimethylsulfoxide; and the mixture thereof.

Examples of the base used for the reaction include inorganic base such as hydroxides of alkali metal or alkaline earth metal (for example sodium hydroxide, potassium hydroxide, calcium hydroxide and so on), hydrides of alkali metal or alkaline earth metal (for example sodium hydride, potassium hydride, calcium hydride and so on), sodium carbonate, potassium carbonate and so on; and organic base such as triethylamine and so on.

Based on one mole of the compound of the formula (b), 1 to 3 mole of the compound of formula (e) and 1 to 3 mole of the base are usually used.

After the reaction, the reaction mixture is poured into water, extracted with an organic solvent, the organic layer is dried and concentrated to give the compound of the present invention. Further, it is possible to purify the obtained the compound of the present invention by chromatography, recrystallization and so on.

Production Method 2

The compound of the present invention, wherein X is R⁸O—N in the formula (a), is produced by making a compound of formula (c):

wherein R¹, R^(2,) R^(3,) R⁴, R⁵, R^(6,) R⁷, X, m and n have the same meaning as described above;

-   react with a hydroxyl amine compound of formula (d):     R⁸O—NH₂   (d)     wherein R⁸ has the same meaning as described above; -   itself or the salt thereof, such as hydrochloric acid salt, sulfuric     acid salt, nitric acid salt and so on.

The reaction is carried out in the presence of a base usually in a solvent. The reaction temperature is usually −78 to 150° C., and the reaction period is 0.1 to 24 hours.

Examples of the solvent used for the reaction include alcohol such as methanol, ethanol and so on; aromatic hydrocarbons such as benzene, toluene, xylene and so on; aliphatic hydrocarbons such as hexane, heptane and so on; ethers such as diethyl ether, tetrahydrofuran, 1,4-dioxane, 1,2-dimethoxyethane, 1,2-diethoxyethane and so on; halogenated hydrocarbons such as dichloromethane, chloroform, 1,2-dichloroethane, chlorobenzene, dichlorobenzene and so on; amides such as N,N-dimethylformamide, N,N-diethylacetamide and so on; dimethylsulfoxide; water and the mixture thereof.

Examples of the base used for the reaction include inorganic base such as hydrides of alkali metal or alkaline earth metal (for example sodium hydride, potassium hydride, calcium hydride and so on), sodium carbonate, potassium carbonate and so on; and organic base such as triethylamine, pyridine and so on.

When excess of hydroxylamine compound of formula (d) itself is used, the base may not be needed.

Based on one mole of the compound of the formula (c), 1 to 3 mole of the hydroxyl amine compound of formula (d) itself or the acid thereof and 1 to 10 mole of the base are usually used.

After the reaction, the reaction mixture is poured into water, extracted with an organic solvent, the organic layer is dried and concentrated to give the compound of the present invention wherein X is R⁸O—N in the formula (a). Further, it is possible to purify the obtained the compound of the present invention by chromatography, recrystallization and so on.

Production Method 3

The compound of the present invention, wherein X is R⁸O—N in the formula (a), is produced by making a compound of formula (f):

wherein R¹, R², R³, R⁴, R⁵, R⁶, R⁷, m and n have the same meaning as described above;

-   react with a compound of formula (g):     L-R⁸   (g)     wherein R⁸ has the same meaning as described above and L represents     halogen (such as chlorine or bromine), methanesulfonyloxy,     benzensulfonyloxy or toluenesulfonyloxy.

The reaction is carried out in the presence of a base usually in a solvent. The reaction temperature is usually −78 to 150° C., and the reaction period is 0.1 to 24 hours.

Examples of the solvent used for the reaction include ketones such as acetone, methyl ethyl ketone and so on; aromatic hydrocarbons such as benzene, toluene, xylene and so on; aliphatic hydrocarbons such as hexane, heptane and so on; ethers such as diethyl ether, tetrahydrofuran, 1,4-dioxane, 1,2-dimethoxyethane, 1,2-diethoxyethane and so on; halogenated hydrocarbons such as chlorobenzene, dichlorobenzene and so on; amides such as N,N-dimethylformamide, N,N-diethylacetamide and so on; nitrites such as acetonitrile and so on; dimethylsulfoxide; and the mixture thereof.

Examples of the base used for the reaction include inorganic base such as hydroxides of alkali metal or alkaline earth metal (for example sodium hydroxide, potassium hydroxide, calcium hydroxide and so on), hydrides of alkali metal or alkaline earth metal (for example sodium hydride, potassium hydride, calcium hydride and so on), sodium carbonate, potassium carbonate and so on; and organic base such as triethylamine.

Based on one mole of the compound of the formula (f), 1 to 1.5 mole of the compound of formula (g) and 1 to 1.2 mole of the base are usually used.

After the reaction, the reaction mixture is poured into water, extracted with an organic solvent, the organic layer is dried and concentrated to give an objective compound wherein X is R⁸O—N in the formula (a). Further, it is possible to purify the obtained the compound of the present invention by chromatography, recrystallization and so on.

Production Method 4

The compound of the present invention, wherein X is oxygen in the formula (a), is produced by making the compound of formula (h):

wherein R¹, R² and R³ have the same meaning as described above;

-   react with a compound of formula (k):     wherein R⁴, R⁵, R⁶, R⁷, m and n have the same meaning as described     above.

The reaction is carried out in the presence of a base usually in a solvent. The reaction temperature is usually −78 to 150° C., and the reaction period is 0.1 to 24 hours.

Examples of the solvent used for the reaction include aromatic hydrocarbons such as toluene, xylene and so on; aliphatic hydrocarbons such as hexane, heptane and so on; ethers such as diethyl ether, tetrahydrofuran, 1,4-dioxane, 1,2-dimethoxyethane, 1,2-diethoxyethane and so on; amides such as N,N-dimethylformamide, N,N-diethylacetamide and so on; dimethylsulfoxide; and the mixture thereof.

Examples of the base used for the reaction include inorganic base such as hydroxides of alkali metal or alkaline earth metal (for example sodium hydroxide, potassium hydroxide, calcium hydroxide and so on), hydrides of alkali metal or alkaline earth metal (for example sodium hydride, potassium hydride, calcium hydride and so on), sodium carbonate, potassium carbonate and so on; and organic base such as triethylamine and so on.

Based on one mole of the compound of the formula (h), 0.5 to 3 mole of the compound of formula (k) and 1 to 3 mole of the base are usually used.

After the reaction, the reaction mixture is poured into water, extracted with an organic solvent, the organic layer is dried, and concentrated to give the compound of the present invention wherein X is oxygen in the formula (a). Further, it is possible to purify the obtained the compound of the present invention by chromatography, recrystallization and so on.

Next, the methods of producing the intermediates of the present invention are described following.

The compound of formula (b-2):

wherein R¹, R², R^(3,) R⁴, R⁵, R⁸, m and n have the same meaning as described above;

-   for example, can be produced by making a compound of formula (b-1):     wherein R¹, R², R^(3,) R⁴, R⁵, m and n have the same meaning as     described above; -   react with the hydroxyl amine compound of formula (d) itself or the     salt thereof, such as hydrochloric acid salt, sulfuric acid salt,     nitric acid salt and so on.

The reaction is carried out in the presence of a base usually in a solvent. The reaction temperature is usually −78 to 150° C., and the reaction period is 0.1 to 24 hours.

Examples of the solvent used for the reaction include alcohol such as methanol, ethanol and so on; aromatic hydrocarbons such as benzene, toluene, xylene and so on; aliphatic hydrocarbons such as hexane, heptane and so on; ethers such as diethyl ether, tetrahydrofuran, 1,4-dioxane, 1,2-dimethoxyethane, 1,2-diethoxyethane and so on; halogenated hydrocarbons such as dichloromethane, chloroform, 1,2-dichloroethane, chlorobenzene, dichlorobenzene and so on; amides such as N,N-dimethylformamide, N,N-diethylacetamide and so on; dimethylsulfoxide; water and the mixture thereof.

Examples of the base used for the reaction include inorganic base such as hydroxides of alkali metal or alkaline earth metal (for example sodium hydroxide, potassium hydroxide, calcium hydroxide and so on), hydrides of alkali metal or alkaline earth metal (for example sodium hydride, potassium hydride, calcium hydride and so on), sodium carbonate, potassium carbonate and so on; and organic base such as triethylamine and so on. When excess of the hydroxyl amine compound of formula (d) itself is used, the base may not be needed. Based on one mole of the compound of the formula (b-1), 1 to 3 mole of the hydroxyl amine compound of formula (d) itself or the salt thereof and 1 to 10 mole of the base are usually used.

After the reaction, the reaction mixture is poured into water, extracted with an organic solvent, the organic layer is dried and concentrated to give the compound of formula (b-2). Further, it is possible to purify the obtained the compound of formula (b-2) by chromatography, recrystallization and so on.

The compound of formula (b-i), for example, can be produced by making a the compound of formula (h) react with a compound of formula (i):

wherein R⁴, R⁵, m and n have the same meaning as described above.

The reaction is carried out in the presence of a base usually in a solvent. The reaction temperature is usually −78 to 150° C., and the reaction period is 0.1 to 24 hours.

Examples of the solvent used for the reaction include aromatic hydrocarbons such as toluene, xylene and so on; aliphatic hydrocarbons such as hexane, heptane and so on; ethers such as diethyl ether, tetrahydrofuran, 1,4-dioxane, 1,2-dimethoxyethane, 1,2-diethoxyethane and so on; amides such as N,N-dimethylformamide, N,N-diethylacetamide and so on; dimethylsulfoxide; and the mixture thereof.

Examples of the base used for the reaction include inorganic base such as hydroxides of alkali metal or alkaline earth metal (for example sodium hydroxide, potassium hydroxide, calcium hydroxide and so on), hydrides of alkali metal or alkaline earth metal (for example sodium hydride, potassium hydride, calcium hydride and so on), sodium carbonate, potassium carbonate and so on; and organic base such as triethylamine and so on.

Based on one mole of the compound of the formula (h), 0.5 to 3 mole of the compound of formula (i) and 1 to 3 mole of the base are usually used.

After the reaction, the reaction mixture is poured into water, extracted with an organic solvent, the organic layer is dried and concentrated to give the compound of formula (b-1). Further, it is possible to purify the obtained the compound of formula (b-1) by chromatography, recrystallization and so on.

The compound of formula (b-1) can be produced by protecting one of the two phenolic hydroxy groups in the compound of formula (i) with an appropriate protecting group (such as benzyl, tert butyldimethylsilyl and methoxymethyl), subjecting with the reaction described above, and removing the protecting group.

The compounds of the present invention are exemplified below.

TABLE 1 (X represents R⁸O—N) R¹ R² R⁸ CH₃ CH₃ CH₃ CH₃ CH₃ CH₃CH₂ CH₃ CH₃ CH₃CH₂CH₂ CH₃ CH₃ (CH₃)₂CH CH₃ CH₃ CH₃CH₂CH₂CH₂ CH₃ CH₃ CH₃CH₂—(CH₃)CH CH₃ CH₃ (CH₃)₂CH—CH₂ CH₃ CH₃ (CH₃)₃C CH₃ CH₃ CH₃CH₂CH₂CH₂CH₂ CH₃ CH₃ (CH₃)₂CH—CH₂CH₂ CH₃ CH₃ (CH₃)₃C—CH₂ CH₃ CH₃ CH₃CH₂CH₂—(CH₃)CH CH₃ CH₃ (CH₃)₂CH—(CH₃)CH CH₃ CH₃ CH₃CH₂CH₂CH₂CH₂CH₂ CH₃ CH₃ CH₂F CH₃ CH₃ CH₂F—CH₂ CH₃ CH₃ CF₃CH₂ CH₃ CH₃ CF₃CH₂CH₂ CH₃ CH₃ CF₃CH₂CH₂CH₂ CH₃ CH₃ CF₃CH₂CH₂CH₂CH₂ CH₃ CH₃ CH₂Cl—CH₂CH₂ CH₃ CH₃ CH₂Br—CH₂CH₂ CH₃ CH₃ CH₂Cl—CH₂CH₂CH₂ CH₃ CH₃ CH₂Br—CH₂CH₂CH₂ CH₃ CH₃ CH₂Cl—CH₂CH₂CH₂CH₂ CH₃ CH₃ CH₂Br—CH₂CH₂CH₂CH₂ CH₃ CH₃ CH₂═CHCH₂ CH₃ CH₃ CH₂═C(CH₃)—CH₂ CH₃ CH₃ (CH₃)₂C═CHCH₂ CH₃ CH₃ CH₃CH═CHCH₂ CH₃ CH₃ CH₂═CHCH₂CH₂ CH₃ CH₃ CH₃CH₂CH═CHCH₂ CH₃ CH₃ CH₃CH═CHCH₂CH₂ CH₃ CH₃ CH₃CH₂CH₂CH═CHCH₂ CH₃ CH₃ CH₃CH₂CH═CHCH₂CH₂ CH₃ CH₃ CHCl═CHCH₂ CH₃ CH₃ CCl₂═CHCH₂ CH₃ CH₃ CHBr═CHCH₂ CH₃ CH₃ CBr₂═CHCH₂ CH₃ CH₃ CH₂═CClCH₂ CH₃ CH₃ CH₂═CBrCH₂ CH₃ CH₃ CH₂═CFCH₂ CH₃ CH₃ CHCl═CClCH₂ CH₃ CH₃ CHBr═CBrCH₂ CH₃ CH₃ CH₃CCl═CHCH₂ CH₃ CH₃ CF₃CCl═CHCH₂ CH₃ CH₃ CClH₂—CH═CHCH₂ CH₃ CH₃ CBrH₂—CH═CHCH₂ CH₃ CH₃ CF₂═CFCH₂ CH₃ CH₃ CH≡CCH₂ CH₃ CH₃ CH₃C≡CCH₂ CH₃ CH₃ CH₃CH₂C≡CCH₂ CH₃ CH₃ CH₃C≡CCH₂CH₂ CH₃ CH₃ CH≡C—(CH₃)CH CH₃ CH₃ N≡CCH₂ CH₃ CH₃ N≡CCH₂CH₂ CH₃ CH₃ N≡CCH₂CH₂CH₂ CH₃ CH₃ N≡CCH₂CH₂CH₂CH₂ CH₃ CH₃ H CH₃ CH₃ C₆H₅—CH₂ CH₃ CH₃ 2-F—C₆H₄—CH₂ CH₃ CH₃ 3-F—C₆H₄—CH₂ CH₃ CH₃ 4-F—C₆H₄—CH₂ CH₃ CH₃ 2-Cl—C₆H₄—CH₂ CH₃ CH₃ 3-Cl—C₆H₄—CH₂ CH₃ CH₃ 4-Cl—C₆H₄—CH₂ CH₃ CH₃ 2-Br—C₆H₄—CH₂ CH₃ CH₃ 3-Br—C₆H₄—CH₂ CH₃ CH₃ 4-Br—C₆H₄—CH₂ CH₃ CH₃ 4-I—C₆H₄—CH₂ CH₃ CH₃ 2-CH₃—C₆H₄—CH₂ CH₃ CH₃ 3-CH₃—C₆H₄—CH₂ CH₃ CH₃ 4-CH₃—C₆H₄—CH₂ CH₃ CH₃ 4-CF₃—C₆H₄—CH₂ CH₃ CH₃ 4-CH₃CH₂—C₆H₄—CH₂ CH₃ CH₃ 4-(CH₃)₂CH—C₆H₄—CH₂ CH₃ CH₃ 4-CH₃CH₂CH₂—C₆H₄—CH₂ CH₃ CH₃ 4-(CH₃)₃C—C₆H₄—CH₂ CH₃ CH₃ 2,4-(CH₃)₂—C₆H₃—CH₂ CH₃ CH₃ 2,4,6-(CH₃)₃—C₆H₂—CH₂ CH₃ CH₃ 2,4-Cl₂—C₆H₃—CH₂ CH₃ CH₃ 3,4-Cl₂—C₆H₃—CH₂ CH₃ CH₃ 2,5-Cl₂—C₆H₃—CH₂ CH₃ CH₃ 3,5-Cl₂—C₆H₃—CH₂ CH₃ CH₃ 2,6-Cl₂—C₆H₃—CH₂ CH₃ CH₃ 4-CH₃O—C₆H₄—CH₂ CH₃ CH₃ 4-CF₃O—C₆H₄—CH₂ CH₃ CH₃ 4-CH₃CH₂O—C₆H₄—CH₂ CH₃ CH₃ 4-(CH₃)₂CHO—C₆H₄—CH₂ CH₃ CH₃ 4-(CH₃)₃CO—C₆H₄—CH₂ CH₃ CH₃ 4-CH₃OC(═O)—C₆H₄—CH₂ CH₃ CH₃ 4-CH₃CH₂OC(═O)—C₆H₄—CH₂ CH₃ CH₃ 4-CH₃CH₂CH₂OC(═O)—C₆H₄—CH₂ CH₃ CH₃ 4-(CH₃)₂CHOC(═O)—C₆H₄—CH₂ CH₃ CH₃ 4-(CH₃)₃COC(═O)—C₆H₄—CH₂ CH₃ CH₃ CH₂Cl—CH₂ CH₃ CH₃ CCl≡CCH₂ CH₃ CH₃ CBr≡CCH₂ CH₃ CH₃CH₂ CH₃ CH₃ CH₃CH₂ CH₃CH₂ CH₃ CH₃CH₂ CH₃CH₂CH₂ CH₃ CH₃CH₂ (CH₃)₂CH CH₃ CH₃CH₂ CH₃CH₂CH₂CH₂ CH₃ CH₃CH₂ CH₃CH₂—(CH₃)CH CH₃ CH₃CH₂ (CH₃)₂CHCH₂ CH₃ CH₃CH₂ (CH₃)₃C CH₃ CH₃CH₂ CH₃CH₂CH₂CH₂CH₂ CH₃ CH₃CH₂ (CH₃)₂CHCH₂CH₂ CH₃ CH₃CH₂ (CH₃)₃CCH₂ CH₃ CH₃CH₂ CH₃CH₂CH₂—(CH₃)CH CH₃ CH₃CH₂ (CH₃)₂CH—(CH₃)CH CH₃ CH₃CH₂ CH₃CH₂CH₂CH₂CH₂CH₂ CH₃ CH₃CH₂ CH₂F CH₃ CH₃CH₂ CH₂F—CH₂ CH₃ CH₃CH₂ CF₃CH₂ CH₃ CH₃CH₂ CF₃CH₂CH₂ CH₃ CH₃CH₂ CF₃CH₂CH₂CH₂ CH₃ CH₃CH₂ CF₃CH₂CH₂CH₂CH₂ CH₃ CH₃CH₂ CH₂Cl—CH₂CH₂ CH₃ CH₃CH₂ CH₂Br—CH₂CH₂ CH₃ CH₃CH₂ CH₂Cl—CH₂CH₂CH₂ CH₃ CH₃CH₂ CH₂Br—CH₂CH₂CH₂ CH₃ CH₃CH₂ CH₂Cl—CH₂CH₂CH₂CH₂ CH₃ CH₃CH₂ CH₂Br—CH₂CH₂CH₂CH₂ CH₃ CH₃CH₂ CH₂═CHCH₂ CH₃ CH₃CH₂ CH₂═C(CH₃)—CH₂ CH₃ CH₃CH₂ (CH₃)₂C═CHCH₂ CH₃ CH₃CH₂ CH₃CH═CHCH₂ CH₃ CH₃CH₂ CH₂═CHCH₂CH₂ CH₃ CH₃CH₂ CH₃CH₂CH═CHCH₂ CH₃ CH₃CH₂ CH₃CH═CHCH₂CH₂ CH₃ CH₃CH₂ CH₃CH₂CH₂CH═CHCH₂ CH₃ CH₃CH₂ CH₃CH₂CH═CHCH₂CH₂ CH₃ CH₃CH₂ CHCl═CHCH₂ CH₃ CH₃CH₂ CCl₂═CHCH₂ CH₃ CH₃CH₂ CHBr═CHCH₂ CH₃ CH₃CH₂ CBr₂═CHCH₂ CH₃ CH₃CH₂ CH₂═CClCH₂ CH₃ CH₃CH₂ CH₂═CBrCH₂ CH₃ CH₃CH₂ CH₂═CFCH₂ CH₃ CH₃CH₂ CHCl═CClCH₂ CH₃ CH₃CH₂ CHBr═CBrCH₂ CH₃ CH₃CH₂ CH₃CCl═CHCH₂ CH₃ CH₃CH₂ CF₃CCl═CHCH₂ CH₃ CH₃CH₂ CClH₂—CH═CHCH₂ CH₃ CH₃CH₂ CBrH₂—CH═CHCH₂ CH₃ CH₃CH₂ CF₂═CFCH₂ CH₃ CH₃CH₂ CH≡CCH₂ CH₃ CH₃CH₂ CH₃C≡CCH₂ CH₃ CH₃CH₂ CH₃CH₂C≡CCH₂ CH₃ CH₃CH₂ CH₃C≡CCH₂CH₂ CH₃ CH₃CH₂ CH≡C—(CH₃)CH CH₃ CH₃CH₂ N≡CCH₂ CH₃ CH₃CH₂ N≡CCH₂CH₂ CH₃ CH₃CH₂ N≡CCH₂CH₂CH₂ CH₃ CH₃CH₂ N≡CCH₂CH₂CH₂CH₂ CH₃ CH₃CH₂ H CH₃ CH₃CH₂ C₆H₅—CH₂ CH₃ CH₃CH₂ 2-F—C₆H₄—CH₂ CH₃ CH₃CH₂ 3-F—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-F—C₆H₄—CH₂ CH₃ CH₃CH₂ 2-Cl—C₆H₄—CH₂ CH₃ CH₃CH₂ 3-Cl—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-Cl—C₆H₄—CH₂ CH₃ CH₃CH₂ 2-Br—C₆H₄—CH₂ CH₃ CH₃CH₂ 3-Br—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-Br—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-I—C₆H₄—CH₂ CH₃ CH₃CH₂ 2-CH₃—C₆H₄—CH₂ CH₃ CH₃CH₂ 3-CH₃—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-CH₃—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-CF₃—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-CH₃CH₂—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-(CH₃)₂CH—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-CH₃CH₂CH₂—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-(CH₃)₃C—C₆H₄—CH₂ CH₃ CH₃CH₂ 2,4-(CH₃)₂—C₆H₃—CH₂ CH₃ CH₃CH₂ 2,4,6-(CH₃)₃—C₆H₂—CH₂ CH₃ CH₃CH₂ 2,4-Cl₂—C₆H₃—CH₂ CH₃ CH₃CH₂ 3,4-Cl₂—C₆H₃—CH₂ CH₃ CH₃CH₂ 2,5-Cl₂—C₆H₃—CH₂ CH₃ CH₃CH₂ 3,5-Cl₂—C₆H₃—CH₂ CH₃ CH₃CH₂ 2,6-Cl₂—C₆H₃—CH₂ CH₃ CH₃CH₂ 4-CH₃O—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-CF₃O—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-CH₃CH₂O—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-(CH₃)₂CHO—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-(CH₃)₃CO—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-CH₃OC(═O)—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-CH₃CH₂OC(═O)—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-CH₃CH₂CH₂OC(═O)—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-(CH₃)₂CHOC(═O)—C₆H₄—CH₂ CH₃ CH₃CH₂ 4-(CH₃)₃COC(═O)—C₆H₄—CH₂ CH₃ CH₃CH₂ CH₂Cl—CH₂ CH₃ CH₃CH₂ CCl≡CCH₂ CH₃ CH₃CH₂ CBr≡CCH₂ CH₃ (CH₃)₂CH CH₃ CH₃ (CH₃)₂CH CH₃CH₂ CH₃ (CH₃)₂CH CH₃CH₂CH₂ CH₃ (CH₃)₂CH (CH₃)₂CH CH₃ (CH₃)₂CH CH₃CH₂CH₂CH₂ CH₃ (CH₃)₂CH CH₃CH₂—(CH₃)CH CH₃ (CH₃)₂CH (CH₃)₂CHCH₂ CH₃ (CH₃)₂CH (CH₃)₃C CH₃ (CH₃)₂CH CH₃CH₂CH₂CH₂CH₂ CH₃ (CH₃)₂CH (CH₃)₂CHCH₂CH₂ CH₃ (CH₃)₂CH (CH₃)₃CCH₂ CH₃ (CH₃)₂CH CH₃CH₂CH₂—(CH₃)CH CH₃ (CH₃)₂CH (CH₃)₂CH—(CH₃)CH CH₃ (CH₃)₂CH CH₃CH₂CH₂CH₂CH₂CH₂ CH₃ (CH₃)₂CH CH₂F CH₃ (CH₃)₂CH CH₂F—CH₂ CH₃ (CH₃)₂CH CF₃CH₂ CH₃ (CH₃)₂CH CF₃CH₂CH₂ CH₃ (CH₃)₂CH CF₃CH₂CH₂CH₂ CH₃ (CH₃)₂CH CF₃CH₂CH₂CH₂CH₂ CH₃ (CH₃)₂CH CH₂Cl—CH₂CH₂ CH₃ (CH₃)₂CH CH₂Br—CH₂CH₂ CH₃ (CH₃)₂CH CH₂Cl—CH₂CH₂CH₂ CH₃ (CH₃)₂CH CH₂Br—CH₂CH₂CH₂ CH₃ (CH₃)₂CH CH₂Cl—CH₂CH₂CH₂CH₂ CH₃ (CH₃)₂CH CH₂Br—CH₂CH₂CH₂CH₂ CH₃ (CH₃)₂CH CH₂═CHCH₂ CH₃ (CH₃)₂CH CH₂═C(CH₃)—CH₂ CH₃ (CH₃)₂CH (CH₃)₂C═CHCH₂ CH₃ (CH₃)₂CH CH₃CH═CHCH₂ CH₃ (CH₃)₂CH CH₂═CHCH₂CH₂ CH₃ (CH₃)₂CH CH₃CH₂CH═CHCH₂ CH₃ (CH₃)₂CH CH₃CH═CHCH₂CH₂ CH₃ (CH₃)₂CH CH₃CH₂CH₂CH═CHCH₂ CH₃ (CH₃)₂CH CH₃CH₂CH═CHCH₂CH₂ CH₃ (CH₃)₂CH CHCl═CHCH₂ CH₃ (CH₃)₂CH CCl₂═CHCH₂ CH₃ (CH₃)₂CH CHBr═CHCH₂ CH₃ (CH₃)₂CH CBr₂═CHCH₂ CH₃ (CH₃)₂CH CH₂═CClCH₂ CH₃ (CH₃)₂CH CH₂═CBrCH₂ CH₃ (CH₃)₂CH CH₂═CFCH₂ CH₃ (CH₃)₂CH CHCl═CClCH₂ CH₃ (CH₃)₂CH CHBr═CBrCH₂ CH₃ (CH₃)₂CH CH₃CCl═CHCH₂ CH₃ (CH₃)₂CH CF₃CCl═CHCH₂ CH₃ (CH₃)₂CH CClH₂CH═CHCH₂ CH₃ (CH₃)₂CH CBrH₂CH═CHCH₂ CH₃ (CH₃)₂CH CF₂═CFCH₂ CH₃ (CH₃)₂CH CH≡CCH₂ CH₃ (CH₃)₂CH CH₃C≡CCH₂ CH₃ (CH₃)₂CH CH₃CH₂C≡CCH₂ CH₃ (CH₃)₂CH CH₃C≡CCH₂CH₂ CH₃ (CH₃)₂CH CH≡C—(CH₃)CH CH₃ (CH₃)₂CH N≡CCH₂ CH₃ (CH₃)₂CH N≡CCH₂CH₂ CH₃ (CH₃)₂CH N≡CCH₂CH₂CH₂ CH₃ (CH₃)₂CH N≡CCH₂CH₂CH₂CH₂ CH₃ (CH₃)₂CH H CH₃ (CH₃)₂CH C₆H₅—CH₂ CH₃ (CH₃)₂CH 2-F—C₆H₄—CH₂ CH₃ (CH₃)₂CH 3-F—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-F—C₆H₄—CH₂ CH₃ (CH₃)₂CH 2-Cl—C₆H₄—CH₂ CH₃ (CH₃)₂CH 3-Cl—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-Cl—C₆H₄—CH₂ CH₃ (CH₃)₂CH 2-Br—C₆H₄—CH₂ CH₃ (CH₃)₂CH 3-Br—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-Br—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-I—C₆H₄—CH₂ CH₃ (CH₃)₂CH 2-CH₃—C₆H₄—CH₂ CH₃ (CH₃)₂CH 3-CH₃—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-CH₃—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-CF₃—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-CH₃CH₂—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-(CH₃)₂CH—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-CH₃CH₂CH₂—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-(CH₃)₃C—C₆H₄—CH₂ CH₃ (CH₃)₂CH 2,4-(CH₃)₂—C₆H₃—CH₂ CH₃ (CH₃)₂CH 2,4,6-(CH₃)₃—C₆H₂—CH₂ CH₃ (CH₃)₂CH 2,4-Cl₂—C₆H₃—CH₂ CH₃ (CH₃)₂CH 3,4-Cl₂—C₆H₃—CH₂ CH₃ (CH₃)₂CH 2,5-Cl₂—C₆H₃—CH₂ CH₃ (CH₃)₂CH 3,5-Cl₂—C₆H₃—CH₂ CH₃ (CH₃)₂CH 2,6-Cl₂—C₆H₃—CH₂ CH₃ (CH₃)₂CH 4-CH₃O—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-CF₃O—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-CH₃CH₂O—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-(CH₃)₂CHO—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-(CH₃)₃CO—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-CH₃OC(═O)—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-CH₃CH₂OC(═O)—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-CH₃CH₂CH₂OC(═O)—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-(CH₃)₂CHOC(═O)—C₆H₄—CH₂ CH₃ (CH₃)₂CH 4-(CH₃)₃COC(═O)—C₆H₄—CH₂ CH₃ (CH₃)₂CH CH₂Cl—CH₂ CH₃ (CH₃)₂CH CCl≡CCH₂ CH₃ (CH₃)₂CH CBr≡CCH₂ CH₃ (CH₃)₃C CH₃ CH₃ (CH₃)₃C CH₃CH₂ CH₃ (CH₃)₃C CH₃CH₂CH₂ CH₃ (CH₃)₃C (CH₃)₂CH CH₃ (CH₃)₃C CH₃CH₂CH₂CH₂ CH₃ (CH₃)₃C CH₃CH₂—(CH₃)CH CH₃ (CH₃)₃C (CH₃)₂CHCH₂ CH₃ (CH₃)₃C (CH₃)₃C CH₃ (CH₃)₃C CH₃CH₂CH₂CH₂CH₂ CH₃ (CH₃)₃C (CH₃)₂CHCH₂CH₂ CH₃ (CH₃)₃C (CH₃)₃CCH₂ CH₃ (CH₃)₃C CH₃CH₂CH₂—(CH₃)CH CH₃ (CH₃)₃C (CH₃)₂CH—(CH₃)CH CH₃ (CH₃)₃C CH₃CH₂CH₂CH₂CH₂CH₂ CH₃ (CH₃)₃C CH₂F CH₃ (CH₃)₃C CH₂F—CH₂ CH₃ (CH₃)₃C CF₃CH₂ CH₃ (CH₃)₃C CF₃CH₂CH₂ CH₃ (CH₃)₃C CF₃CH₂CH₂CH₂ CH₃ (CH₃)₃C CF₃CH₂CH₂CH₂CH₂ CH₃ (CH₃)₃C CH₂ClCH₂CH₂ CH₃ (CH₃)₃C CH₂Br—CH₂CH₂ CH₃ (CH₃)₃C CH₂Cl—CH₂CH₂CH₂ CH₃ (CH₃)₃C CH₂Br—CH₂CH₂CH₂ CH₃ (CH₃)₃C CH₂Cl—CH₂CH₂CH₂CH₂ CH₃ (CH₃)₃C CH₂Br—CH₂CH₂CH₂CH₂ CH₃ (CH₃)₃C CH₂═CHCH₂ CH₃ (CH₃)₃C CH₂═C(CH₃)—CH₂ CH₃ (CH₃)₃C (CH₃)₂C═CHCH₂ CH₃ (CH₃)₃C CH₃CH═CHCH₂ CH₃ (CH₃)₃C CH₂═CHCH₂CH₂ CH₃ (CH₃)₃C CH₃CH₂CH═CHCH₂ CH₃ (CH₃)₃C CH₃CH═CHCH₂CH₂ CH₃ (CH₃)₃C CH₃CH₂CH₂CH═CHCH₂ CH₃ (CH₃)₃C CH₃CH₂CH═CHCH₂CH₂ CH₃ (CH₃)₃C CHCl═CHCH₂ CH₃ (CH₃)₃C CCl₂═CHCH₂ CH₃ (CH₃)₃C CHBr═CHCH₂ CH₃ (CH₃)₃C CBr₂═CHCH₂ CH₃ (CH₃)₃C CH₂═CClCH₂ CH₃ (CH₃)₃C CH₂═CBrCH₂ CH₃ (CH₃)₃C CH₂═CFCH₂ CH₃ (CH₃)₃C CHCl═CClCH₂ CH₃ (CH₃)₃C CHBr═CBrCH₂ CH₃ (CH₃)₃C CH₃CCl═CHCH₂ CH₃ (CH₃)₃C CF₃CCl═CHCH₂ CH₃ (CH₃)₃C CClH₂CH═CHCH₂ CH₃ (CH₃)₃C CBrH₂CH═CHCH₂ CH₃ (CH₃)₃C CF₂═CFCH₂ CH₃ (CH₃)₃C CH≡CCH₂ CH₃ (CH₃)₃C CH₃C≡CCH₂ CH₃ (CH₃)₃C CH₃CH₂C≡CCH₂ CH₃ (CH₃)₃C CH₃C≡CCH₂CH₂ CH₃ (CH₃)₃C CH≡C—(CH₃)CH CH₃ (CH₃)₃C N≡CCH₂ CH₃ (CH₃)₃C N≡CCH₂CH₂ CH₃ (CH₃)₃C N≡CCH₂CH₂CH₂ CH₃ (CH₃)₃C N≡CCH₂CH₂CH₂CH₂ CH₃ (CH₃)₃C H CH₃ (CH₃)₃C C₆H₅—CH₂ CH₃ (CH₃)₃C 2-F—C₆H₄—CH₂ CH₃ (CH₃)₃C 3-F—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-F—C₆H₄—CH₂ CH₃ (CH₃)₃C 2-Cl—C₆H₄—CH₂ CH₃ (CH₃)₃C 3-Cl—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-Cl—C₆H₄—CH₂ CH₃ (CH₃)₃C 2-Br—C₆H₄—CH₂ CH₃ (CH₃)₃C 3-Br—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-Br—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-I—C₆H₄—CH₂ CH₃ (CH₃)₃C 2-CH₃—C₆H₄—CH₂ CH₃ (CH₃)₃C 3-CH₃—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-CH₃—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-CF₃—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-CH₃CH₂—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-(CH₃)₂CH—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-CH₃CH₂CH₂—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-(CH₃)₃C—C₆H₄—CH₂ CH₃ (CH₃)₃C 2,4-(CH₃)₂—C₆H₃—CH₂ CH₃ (CH₃)₃C 2,4,6-(CH₃)₃—C₆H₂—CH₂ CH₃ (CH₃)₃C 2,4-Cl₂—C₆H₃—CH₂ CH₃ (CH₃)₃C 3,4-Cl₂—C₆H₃—CH₂ CH₃ (CH₃)₃C 2,5-Cl₂—C₆H₃—CH₂ CH₃ (CH₃)₃C 3,5-Cl₂—C₆H₃—CH₂ CH₃ (CH₃)₃C 2,6-Cl₂—C₆H₃—CH₂ CH₃ (CH₃)₃C 4-CH₃O—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-CF₃O—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-CH₃CH₂O—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-(CH₃)₂CHO—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-(CH₃)₃CO—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-CH₃OC(═O)—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-CH₃CH₂OC(═O)—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-CH₃CH₂CH₂OC(═O)—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-(CH₃)₂CHOC(═O)—C₆H₄—CH₂ CH₃ (CH₃)₃C 4-(CH₃)₃COC(═O)—C₆H₄—CH₂ CH₃ (CH₃)₃C CH₂Cl—CH₂ CH₃ (CH₃)₃C CCl≡CCH₂ CH₃ (CH₃)₃C CBr≡CCH₂ CH₃CH₂ CH₃ CH₃ CH₃CH₂ CH₃ CH₃CH₂ CH₃CH₂ CH₃ CH₃CH₂CH₂ CH₃CH₂ CH₃ (CH₃)₂CH CH₃CH₂ CH₃ CH₃CH₂CH₂CH₂ CH₃CH₂ CH₃ CH₃CH₂—(CH₃)CH CH₃CH₂ CH₃ (CH₃)₂CHCH₂ CH₃CH₂ CH₃ (CH₃)₃C CH₃CH₂ CH₃ CH₃CH₂CH₂CH₂CH₂ CH₃CH₂ CH₃ (CH₃)₂CHCH₂CH₂ CH₃CH₂ CH₃ (CH₃)₃CCH₂ CH₃CH₂ CH₃ CH₃CH₂CH₂—(CH₃)CH CH₃CH₂ CH₃ (CH₃)₂CH—(CH₃)CH CH₃CH₂ CH₃ CH₃CH₂CH₂CH₂CH₂CH₂ CH₃CH₂ CH₃ CH₂F CH₃CH₂ CH₃ CH₂F—CH₂ CH₃CH₂ CH₃ CF₃CH₂ CH₃CH₂ CH₃ CF₃CH₂CH₂ CH₃CH₂ CH₃ CF₃CH₂CH₂CH₂ CH₃CH₂ CH₃ CF₃CH₂CH₂CH₂CH₂ CH₃CH₂ CH₃ CH₂Cl—CH₂CH₂ CH₃CH₂ CH₃ CH₂Br—CH₂CH₂ CH₃CH₂ CH₃ CH₂Cl—CH₂CH₂CH₂ CH₃CH₂ CH₃ CH₂Br—CH₂CH₂CH₂ CH₃CH₂ CH₃ CH₂Cl—CH₂CH₂CH₂CH₂ CH₃CH₂ CH₃ CH₂Br—CH₂CH₂CH₂CH₂ CH₃CH₂ CH₃ CH₂═CHCH₂ CH₃CH₂ CH₃ CH₂═C(CH₃)—CH₂ CH₃CH₂ CH₃ (CH₃)₂C═CHCH₂ CH₃CH₂ CH₃ CH₃CH═CHCH₂ CH₃CH₂ CH₃ CH₂═CHCH₂CH₂ CH₃CH₂ CH₃ CH₃CH₂CH═CHCH₂ CH₃CH₂ CH₃ CH₃CH═CHCH₂CH₂ CH₃CH₂ CH₃ CH₃CH₂CH₂CH═CHCH₂ CH₃CH₂ CH₃ CH₃CH₂CH═CHCH₂CH₂ CH₃CH₂ CH₃ CHCl═CHCH₂ CH₃CH₂ CH₃ CCl₂═CHCH₂ CH₃CH₂ CH₃ CHBr═CHCH₂ CH₃CH₂ CH₃ CBr₂═CHCH₂ CH₃CH₂ CH₃ CH₂═CClCH₂ CH₃CH₂ CH₃ CH₂═CBrCH₂ CH₃CH₂ CH₃ CH₂═CFCH₂ CH₃CH₂ CH₃ CHCl═CClCH₂ CH₃CH₂ CH₃ CHBr═CBrCH₂ CH₃CH₂ CH₃ CH₃CCl═CHCH₂ CH₃CH₂ CH₃ CF₃CCl═CHCH₂ CH₃CH₂ CH₃ CClH₂CH═CHCH₂ CH₃CH₂ CH₃ CBrH₂CH═CHCH₂ CH₃CH₂ CH₃ CF₂═CFCH₂ CH₃CH₂ CH₃ CH≡CCH₂ CH₃CH₂ CH₃ CH₃C≡CCH₂ CH₃CH₂ CH₃ CH₃CH₂C≡CCH₂ CH₃CH₂ CH₃ CH₃C≡CCH₂CH₂ CH₃CH₂ CH₃ CH≡C—(CH₃)CH CH₃CH₂ CH₃ N≡CCH₂ CH₃CH₂ CH₃ N≡CCH₂CH₂ CH₃CH₂ CH₃ N≡CCH₂CH₂CH₂ CH₃CH₂ CH₃ N≡CCH₂CH₂CH₂CH₂ CH₃CH₂ CH₃ H CH₃CH₂ CH₃ C₆H₅—CH₂ CH₃CH₂ CH₃ 2-F—C₆H₄—CH₂ CH₃CH₂ CH₃ 3-F—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-F—C₆H₄—CH₂ CH₃CH₂ CH₃ 2-Cl—C₆H₄—CH₂ CH₃CH₂ CH₃ 3-Cl—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-Cl—C₆H₄—CH₂ CH₃CH₂ CH₃ 2-Br—C₆H₄—CH₂ CH₃CH₂ CH₃ 3-Br—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-Br—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-I—C₆H₄—CH₂ CH₃CH₂ CH₃ 2-CH₃—C₆H₄—CH₂ CH₃CH₂ CH₃ 3-CH₃—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-CH₃—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-CF₃—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-CH₃CH₂—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-(CH₃)₂CH—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-CH₃CH₂CH₂—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-(CH₃)₃C—C₆H₄—CH₂ CH₃CH₂ CH₃ 2,4-(CH₃)₂—C₆H₃—CH₂ CH₃CH₂ CH₃ 2,4,6-(CH₃)₃—C₆H₂—CH₂ CH₃CH₂ CH₃ 2,4-Cl₂—C₆H₃—CH₂ CH₃CH₂ CH₃ 3,4-Cl₂—C₆H₃—CH₂ CH₃CH₂ CH₃ 2,5-Cl₂—C₆H₃—CH₂ CH₃CH₂ CH₃ 3,5-Cl₂—C₆H₃—CH₂ CH₃CH₂ CH₃ 2,6-Cl₂—C₆H₃—CH₂ CH₃CH₂ CH₃ 4-CH₃O—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-CF₃O—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-CH₃CH₂O—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-(CH₃)₂CHO—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-(CH₃)₃CO—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-CH₃OC(═O)—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-CH₃CH₂OC(═O)—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-CH₃CH₂CH₂OC(═O)—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-(CH₃)₂CHOC(═O)—C₆H₄—CH₂ CH₃CH₂ CH₃ 4-(CH₃)₃COC(═O)—C₆H₄—CH₂ CH₃CH₂ CH₃ CH₂Cl—CH₂ CH₃CH₂ CH₃ CCl≡CCH₂ CH₃CH₂ CH₃ CBr≡CCH₂ CH₃CH₂ CH₃CH₂ CH₃ CH₃CH₂ CH₃CH₂ CH₃CH₂ CH₃CH₂ CH₃CH₂ CH₃CH₂CH₂ CH₃CH₂ CH₃CH₂ (CH₃)₂CH CH₃CH₂ CH₃CH₂ CH₃CH₂CH₂CH₂ CH₃CH₂ CH₃CH₂ CH₃CH₂—(CH₃)CH CH₃CH₂ CH₃CH₂ (CH₃)₂CHCH₂ CH₃CH₂ CH₃CH₂ (CH₃)₃C CH₃CH₂ CH₃CH₂ CH₃CH₂CH₂CH₂CH₂ CH₃CH₂ CH₃CH₂ (CH₃)₂CHCH₂CH₂ CH₃CH₂ CH₃CH₂ (CH₃)₃CCH₂ CH₃CH₂ CH₃CH₂ CH₃CH₂CH₂—(CH₃)CH CH₃CH₂ CH₃CH₂ (CH₃)₂CH—(CH₃)CH CH₃CH₂ CH₃CH₂ CH₃CH₂CH₂CH₂CH₂CH₂ CH₃CH₂ CH₃CH₂ CH₂F CH₃CH₂ CH₃CH₂ CH₂F—CH₂ CH₃CH₂ CH₃CH₂ CF₃CH₂ CH₃CH₂ CH₃CH₂ CF₃CH₂CH₂ CH₃CH₂ CH₃CH₂ CF₃CH₂CH₂CH₂ CH₃CH₂ CH₃CH₂ CF₃CH₂CH₂CH₂CH₂ CH₃CH₂ CH₃CH₂ CH₂Cl—CH₂CH₂ CH₃CH₂ CH₃CH₂ CH₂Br—CH₂CH₂ CH₃CH₂ CH₃CH₂ CH₂Cl—CH₂CH₂CH₂ CH₃CH₂ CH₃CH₂ CH₂Br—CH₂CH₂CH₂ CH₃CH₂ CH₃CH₂ CH₂Cl—CH₂CH₂CH₂CH₂ CH₃CH₂ CH₃CH₂ CH₂Br—CH₂CH₂CH₂CH₂ CH₃CH₂ CH₃CH₂ CH₂═CHCH₂ CH₃CH₂ CH₃CH₂ CH₂═C(CH₃)—CH₂ CH₃CH₂ CH₃CH₂ (CH₃)₂C═CHCH₂ CH₃CH₂ CH₃CH₂ CH₃CH═CHCH₂ CH₃CH₂ CH₃CH₂ CH₂═CHCH₂CH₂ CH₃CH₂ CH₃CH₂ CH₃CH₂CH═CHCH₂ CH₃CH₂ CH₃CH₂ CH₃CH═CHCH₂CH₂ CH₃CH₂ CH₃CH₂ CH₃CH₂CH₂CH═CHCH₂ CH₃CH₂ CH₃CH₂ CH₃CH₂CH═CHCH₂CH₂ CH₃CH₂ CH₃CH₂ CHCl═CHCH₂ CH₃CH₂ CH₃CH₂ CCl₂═CHCH₂ CH₃CH₂ CH₃CH₂ CHBr═CHCH₂ CH₃CH₂ CH₃CH₂ CBr₂═CHCH₂ CH₃CH₂ CH₃CH₂ CH₂═CClCH₂ CH₃CH₂ CH₃CH₂ CH₂═CBrCH₂ CH₃CH₂ CH₃CH₂ CH₂═CFCH₂ CH₃CH₂ CH₃CH₂ CHCl═CClCH₂ CH₃CH₂ CH₃CH₂ CHBr═CBrCH₂ CH₃CH₂ CH₃CH₂ CH₃CCl═CHCH₂ CH₃CH₂ CH₃CH₂ CF₃CCl═CHCH₂ CH₃CH₂ CH₃CH₂ CClH₂CH═CHCH₂ CH₃CH₂ CH₃CH₂ CBrH₂CH═CHCH₂ CH₃CH₂ CH₃CH₂ CF₂═CFCH₂ CH₃CH₂ CH₃CH₂ CH≡CCH₂ CH₃CH₂ CH₃CH₂ CH₃C≡CCH₂ CH₃CH₂ CH₃CH₂ CH₃CH₂C≡CCH₂ CH₃CH₂ CH₃CH₂ CH₃C≡CCH₂CH₂ CH₃CH₂ CH₃CH₂ CH≡C—(CH₃)CH CH₃CH₂ CH₃CH₂ N≡CCH₂ CH₃CH₂ CH₃CH₂ N≡CCH₂CH₂ CH₃CH₂ CH₃CH₂ N≡CCH₂CH₂CH₂ CH₃CH₂ CH₃CH₂ N≡CCH₂CH₂CH₂CH₂ CH₃CH₂ CH₃CH₂ H CH₃CH₂ CH₃CH₂ C₆H₅—CH₂ CH₃CH₂ CH₃CH₂ 2-F—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 3-F—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-F—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 2-Cl—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 3-Cl—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-Cl—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 2-Br—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 3-Br—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-Br—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-I—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 2-CH₃—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 3-CH₃—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-CH₃—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-CF₃—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-CH₃CH₂—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-(CH₃)₂CH—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-CH₃CH₂CH₂—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-(CH₃)₃C—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 2,4-(CH₃)₂—C₆H₃—CH₂ CH₃CH₂ CH₃CH₂ 2,4,6-(CH₃)₃—C₆H₂—CH₂ CH₃CH₂ CH₃CH₂ 2,4-Cl₂—C₆H₃—CH₂ CH₃CH₂ CH₃CH₂ 3,4-Cl₂—C₆H₃—CH₂ CH₃CH₂ CH₃CH₂ 2,5-Cl₂—C₆H₃—CH₂ CH₃CH₂ CH₃CH₂ 3,5-Cl₂—C₆H₃—CH₂ CH₃CH₂ CH₃CH₂ 2,6-Cl₂—C₆H₃—CH₂ CH₃CH₂ CH₃CH₂ 4-CH₃O—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-CF₃O—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-CH₃CH₂O—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-(CH₃)₂CHO—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-(CH₃)₃CO—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-CH₃OC(═O)—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-CH₃CH₂OC(═O)—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-CH₃CH₂CH₂OC(═O)—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-(CH₃)₂CHOC(═O)—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ 4-(CH₃)₃COC(═O)—C₆H₄—CH₂ CH₃CH₂ CH₃CH₂ CH₂Cl—CH₂ CH₃CH₂ CH₃CH₂ CCl≡CCH₂ CH₃CH₂ CH₃CH₂ CBr≡CCH₂ CH₃CH₂ (CH₃)₂CH CH₃ CH₃CH₂ (CH₃)₂CH CH₃CH₂ CH₃CH₂ (CH₃)₂CH CH₃CH₂CH₂ CH₃CH₂ (CH₃)₂CH (CH₃)₂CH CH₃CH₂ (CH₃)₂CH CH₃CH₂CH₂CH₂ CH₃CH₂ (CH₃)₂CH CH₃CH₂—(CH₃)CH CH₃CH₂ (CH₃)₂CH (CH₃)₂CHCH₂ CH₃CH₂ (CH₃)₂CH (CH₃)₃C CH₃CH₂ (CH₃)₂CH CH₃CH₂CH₂CH₂CH₂ CH₃CH₂ (CH₃)₂CH (CH₃)₂CHCH₂CH₂ CH₃CH₂ (CH₃)₂CH (CH₃)₃CCH₂ CH₃CH₂ (CH₃)₂CH CH₃CH₂CH₂—(CH₃)CH CH₃CH₂ (CH₃)₂CH (CH₃)₂CH—(CH₃)CH CH₃CH₂ (CH₃)₂CH CH₃CH₂CH₂CH₂CH₂CH₂ CH₃CH₂ (CH₃)₂CH CH₂F CH₃CH₂ (CH₃)₂CH CH₂F—CH₂ CH₃CH₂ (CH₃)₂CH CF₃CH₂ CH₃CH₂ (CH₃)₂CH CF₃CH₂CH₂ CH₃CH₂ (CH₃)₂CH CF₃CH₂CH₂CH₂ CH₃CH₂ (CH₃)₂CH CF₃CH₂CH₂CH₂CH₂ CH₃CH₂ (CH₃)₂CH CH₂Cl—CH₂CH₂ CH₃CH₂ (CH₃)₂CH CH₂Br—CH₂CH₂ CH₃CH₂ (CH₃)₂CH CH₂Cl—CH₂CH₂CH₂ CH₃CH₂ (CH₃)₂CH CH₂Br—CH₂CH₂CH₂ CH₃CH₂ (CH₃)₂CH CH₂Cl—CH₂CH₂CH₂CH₂ CH₃CH₂ (CH₃)₂CH CH₂Br—CH₂CH₂CH₂CH₂ CH₃CH₂ (CH₃)₂CH CH₂═CHCH₂ CH₃CH₂ (CH₃)₂CH CH₂═C(CH₃)—CH₂ CH₃CH₂ (CH₃)₂CH (CH₃)₂C═CHCH₂ CH₃CH₂ (CH₃)₂CH CH₃CH═CHCH₂ CH₃CH₂ (CH₃)₂CH CH₂═CHCH₂CH₂ CH₃CH₂ (CH₃)₂CH CH₃CH₂CH═CHCH₂ CH₃CH₂ (CH₃)₂CH CH₃CH═CHCH₂CH₂ CH₃CH₂ (CH₃)₂CH CH₃CH₂CH₂CH═CHCH₂ CH₃CH₂ (CH₃)₂CH CH₃CH₂CH═CHCH₂CH₂ CH₃CH₂ (CH₃)₂CH CHCl═CHCH₂ CH₃CH₂ (CH₃)₂CH CCl₂═CHCH₂ CH₃CH₂ (CH₃)₂CH CHBr═CHCH₂ CH₃CH₂ (CH₃)₂CH CBr₂═CHCH₂ CH₃CH₂ (CH₃)₂CH CH₂═CClCH₂ CH₃CH₂ (CH₃)₂CH CH₂═CBrCH₂ CH₃CH₂ (CH₃)₂CH CH₂═CFCH₂ CH₃CH₂ (CH₃)₂CH CHCl═CClCH₂ CH₃CH₂ (CH₃)₂CH CHBr═CBrCH₂ CH₃CH₂ (CH₃)₂CH CH₃CCl═CHCH₂ CH₃CH₂ (CH₃)₂CH CF₃CCl═CHCH₂ CH₃CH₂ (CH₃)₂CH CClH₂CH═CHCH₂ CH₃CH₂ (CH₃)₂CH CBrH₂CH═CHCH₂ CH₃CH₂ (CH₃)₂CH CF₂═CFCH₂ CH₃CH₂ (CH₃)₂CH CH≡CCH₂ CH₃CH₂ (CH₃)₂CH CH₃C≡CCH₂ CH₃CH₂ (CH₃)₂CH CH₃CH₂C≡CCH₂ CH₃CH₂ (CH₃)₂CH CH₃C≡CCH₂CH₂ CH₃CH₂ (CH₃)₂CH CH≡C—(CH₃)CH CH₃CH₂ (CH₃)₂CH N≡CCH₂ CH₃CH₂ (CH₃)₂CH N≡CCH₂CH₂ CH₃CH₂ (CH₃)₂CH N≡CCH₂CH₂CH₂ CH₃CH₂ (CH₃)₂CH N≡CCH₂CH₂CH₂CH₂ CH₃CH₂ (CH₃)₂CH H CH₃CH₂ (CH₃)₂CH C₆H₅—CH₂ CH₃CH₂ (CH₃)₂CH 2-F—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 3-F—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-F—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 2-Cl—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 3-Cl—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-Cl—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 2-Br—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 3-Br—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-Br—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-I—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 2-CH₃—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 3-CH₃—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-CH₃—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-CF₃—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-CH₃CH₂—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-(CH₃)₂CH—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-CH₃CH₂CH₂—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-(CH₃)₃C—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 2,4-(CH₃)₂—C₆H₃—CH₂ CH₃CH₂ (CH₃)₂CH 2,4,6-(CH₃)₃—C₆H₂—CH₂ CH₃CH₂ (CH₃)₂CH 2,4-Cl₂—C₆H₃—CH₂ CH₃CH₂ (CH₃)₂CH 3,4-Cl₂—C₆H₃—CH₂ CH₃CH₂ (CH₃)₂CH 2,5-Cl₂—C₆H₃—CH₂ CH₃CH₂ (CH₃)₂CH 3,5-Cl₂—C₆H₃—CH₂ CH₃CH₂ (CH₃)₂CH 2,6-Cl₂—C₆H₃—CH₂ CH₃CH₂ (CH₃)₂CH 4-CH₃O—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-CF₃O—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-CH₃CH₂O—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-(CH₃)₂CHO—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-(CH₃)₃CO—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-CH₃OC(═O)—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-CH₃CH₂OC(═O)—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-CH₃CH₂CH₂OC(═O)—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-(CH₃)₂CHOC(═O)—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH 4-(CH₃)₃COC(═O)—C₆H₄—CH₂ CH₃CH₂ (CH₃)₂CH CH₂Cl—CH₂ CH₃CH₂ (CH₃)₂CH CCl≡CCH₂ CH₃CH₂ (CH₃)₂CH CBr≡CCH₂ CH₃CH₂ (CH₃)₃C CH₃ CH₃CH₂ (CH₃)₃C CH₃CH₂ CH₃CH₂ (CH₃)₃C CH₃CH₂CH₂ CH₃CH₂ (CH₃)₃C (CH₃)₂CH CH₃CH₂ (CH₃)₃C CH₃CH₂CH₂CH₂ CH₃CH₂ (CH₃)₃C CH₃CH₂—(CH₃)CH CH₃CH₂ (CH₃)₃C (CH₃)₂CHCH₂ CH₃CH₂ (CH₃)₃C (CH₃)₃C CH₃CH₂ (CH₃)₃C CH₃CH₂CH₂CH₂CH₂ CH₃CH₂ (CH₃)₃C (CH₃)₂CHCH₂CH₂ CH₃CH₂ (CH₃)₃C (CH₃)₃CCH₂ CH₃CH₂ (CH₃)₃C CH₃CH₂CH₂—(CH₃)CH CH₃CH₂ (CH₃)₃C (CH₃)₂CH—(CH₃)CH CH₃CH₂ (CH₃)₃C CH₃CH₂CH₂CH₂CH₂CH₂ CH₃CH₂ (CH₃)₃C CH₂F CH₃CH₂ (CH₃)₃C CH₂F—CH₂ CH₃CH₂ (CH₃)₃C CF₃CH₂ CH₃CH₂ (CH₃)₃C CF₃CH₂CH₂ CH₃CH₂ (CH₃)₃C CF₃CH₂CH₂CH₂ CH₃CH₂ (CH₃)₃C CF₃CH₂CH₂CH₂CH₂ CH₃CH₂ (CH₃)₃C CH₂Cl—CH₂CH₂ CH₃CH₂ (CH₃)₃C CH₂Br—CH₂CH₂ CH₃CH₂ (CH₃)₃C CH₂Cl—CH₂CH₂CH₂ CH₃CH₂ (CH₃)₃C CH₂Br—CH₂CH₂CH₂ CH₃CH₂ (CH₃)₃C CH₂Cl—CH₂CH₂CH₂CH₂ CH₃CH₂ (CH₃)₃C CH₂Br—CH₂CH₂CH₂CH₂ CH₃CH₂ (CH₃)₃C CH₂═CHCH₂ CH₃CH₂ (CH₃)₃C CH₂═C(CH₃)—CH₂ CH₃CH₂ (CH₃)₃C (CH₃)₂C═CHCH₂ CH₃CH₂ (CH₃)₃C CH₃CH═CHCH₂ CH₃CH₂ (CH₃)₃C CH₂═CHCH₂CH₂ CH₃CH₂ (CH₃)₃C CH₃CH₂CH═CHCH₂ CH₃CH₂ (CH₃)₃C CH₃CH═CHCH₂CH₂ CH₃CH₂ (CH₃)₃C CH₃CH₂CH₂CH═CHCH₂ CH₃CH₂ (CH₃)₃C CH₃CH₂CH═CHCH₂CH₂ CH₃CH₂ (CH₃)₃C CHCl═CHCH₂ CH₃CH₂ (CH₃)₃C CCl₂═CHCH₂ CH₃CH₂ (CH₃)₃C CHBr═CHCH₂ CH₃CH₂ (CH₃)₃C CBr₂═CHCH₂ CH₃CH₂ (CH₃)₃C CH₂═CClCH₂ CH₃CH₂ (CH₃)₃C CH₂═CBrCH₂ CH₃CH₂ (CH₃)₃C CH₂═CFCH₂ CH₃CH₂ (CH₃)₃C CHCl═CClCH₂ CH₃CH₂ (CH₃)₃C CHBr═CBrCH₂ CH₃CH₂ (CH₃)₃C CH₃CCl═CHCH₂ CH₃CH₂ (CH₃)₃C CF₃CCl═CHCH₂ CH₃CH₂ (CH₃)₃C CClH₂CH═CHCH₂ CH₃CH₂ (CH₃)₃C CBrH₂CH═CHCH₂ CH₃CH₂ (CH₃)₃C CF₂═CFCH₂ CH₃CH₂ (CH₃)₃C CH≡CCH₂ CH₃CH₂ (CH₃)₃C CH₃C≡CCH₂ CH₃CH₂ (CH₃)₃C CH₃CH₂C≡CCH₂ CH₃CH₂ (CH₃)₃C CH₃C≡CCH₂CH₂ CH₃CH₂ (CH₃)₃C CH≡C—(CH₃)CH CH₃CH₂ (CH₃)₃C N≡CCH₂ CH₃CH₂ (CH₃)₃C N≡CCH₂CH₂ CH₃CH₂ (CH₃)₃C N≡CCH₂CH₂CH₂ CH₃CH₂ (CH₃)₃C N≡CCH₂CH₂CH₂CH₂ CH₃CH₂ (CH₃)₃C H CH₃CH₂ (CH₃)₃C C₆H₅—CH₂ CH₃CH₂ (CH₃)₃C 2-F—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 3-F—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-F—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 2-Cl—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 3-Cl—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-Cl—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 2-Br—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 3-Br—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-Br—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-I—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 2-CH₃—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 3-CH₃—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-CH₃—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-CF₃—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-CH₃CH₂—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-(CH₃)₂CH—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-CH₃CH₂CH₂—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-(CH₃)₃C—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 2,4-(CH₃)₂—C₆H₃—CH₂ CH₃CH₂ (CH₃)₃C 2,4,6-(CH₃)₃—C₆H₂—CH₂ CH₃CH₂ (CH₃)₃C 2,4-Cl₂—C₆H₃—CH₂ CH₃CH₂ (CH₃)₃C 3,4-Cl₂—C₆H₃—CH₂ CH₃CH₂ (CH₃)₃C 2,5-Cl₂—C₆H₃—CH₂ CH₃CH₂ (CH₃)₃C 3,5-Cl₂—C₆H₃—CH₂ CH₃CH₂ (CH₃)₃C 2,6-Cl₂—C₆H₃—CH₂ CH₃CH₂ (CH₃)₃C 4-CH₃O—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-CF₃O—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-CH₃CH₂O—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-(CH₃)₂CHO—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-(CH₃)₃CO—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-CH₃OC(═O)—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-CH₃CH₂OC(═O)—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-CH₃CH₂CH₂OC(═O)—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-(CH₃)₂CHOC(═O)—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C 4-(CH₃)₃COC(═O)—C₆H₄—CH₂ CH₃CH₂ (CH₃)₃C CH₂Cl—CH₂ CH₃CH₂ (CH₃)₃C CCl≡CCH₂ CH₃CH₂ (CH₃)₃C CBr≡CCH₂ CF₃ CH₃ CH₃ CF₃ CH₃ CH₃CH₂ CF₃ CH₃ CH₃CH₂CH₂ CF₃ CH₃ (CH₃)₂CH CF₃ CH₃ CH₃CH₂CH₂CH₂ CF₃ CH₃ CH₃CH₂—(CH₃)CH CF₃ CH₃ (CH₃)₂CHCH₂ CF₃ CH₃ (CH₃)₃C CF₃ CH₃ CH₃CH₂CH₂CH₂CH₂ CF₃ CH₃ (CH₃)₂CHCH₂CH₂ CF₃ CH₃ (CH₃)₃CCH₂ CF₃ CH₃ CH₃CH₂CH₂—(CH₃)CH CF₃ CH₃ (CH₃)₂CH—(CH₃)CH CF₃ CH₃ CH₃CH₂CH₂CH₂CH₂CH₂ CF₃ CH₃ CH₂F CF₃ CH₃ CH₂FCH₂ CF₃ CH₃ CF₃CH₂ CF₃ CH₃ CF₃CH₂CH₂ CF₃ CH₃ CF₃CH₂CH₂CH₂ CF₃ CH₃ CF₃CH₂CH₂CH₂CH₂ CF₃ CH₃ CH₂ClCH₂CH₂ CF₃ CH₃ CH₂BrCH₂CH₂ CF₃ CH₃ CH₂ClCH₂CH₂CH₂ CF₃ CH₃ CH₂BrCH₂CH₂CH₂ CF₃ CH₃ CH₂ClCH₂CH₂CH₂CH₂ CF₃ CH₃ CH₂BrCH₂CH₂CH₂CH₂ CF₃ CH₃ CH₂═CHCH₂ CF₃ CH₃ CH₂═C(CH₃)—CH₂ CF₃ CH₃ (CH₃)₂C═CHCH₂ CF₃ CH₃ CH₃CH═CHCH₂ CF₃ CH₃ CH₂═CHCH₂CH₂ CF₃ CH₃ CH₃CH₂CH═CHCH₂ CF₃ CH₃ CH₃CH═CHCH₂CH₂ CF₃ CH₃ CH₃CH₂CH₂CH═CHCH₂ CF₃ CH₃ CH₃CH₂CH═CHCH₂CH₂ CF₃ CH₃ CHCl═CHCH₂ CF₃ CH₃ CCl₂═CHCH₂ CF₃ CH₃ CHBr═CHCH₂ CF₃ CH₃ CBr₂═CHCH₂ CF₃ CH₃ CH₂═CClCH₂ CF₃ CH₃ CH₂═CBrCH₂ CF₃ CH₃ CH₂═CFCH₂ CF₃ CH₃ CHCl═CClCH₂ CF₃ CH₃ CHBr═CBrCH₂ CF₃ CH₃ CH₃CCl═CHCH₂ CF₃ CH₃ CF₃CCl═CHCH₂ CF₃ CH₃ CClH₂—CH═CHCH₂ CF₃ CH₃ CBrH₂—CH═CHCH₂ CF₃ CH₃ CF₂═CFCH₂ CF₃ CH₃ CH≡CCH₂ CF₃ CH₃ CH₃C≡CCH₂ CF₃ CH₃ CH₃CH₂C≡CCH₂ CF₃ CH₃ CH₃C≡CCH₂CH₂ CF₃ CH₃ CH≡C—(CH₃)CH CF₃ CH₃ N≡CCH₂ CF₃ CH₃ N≡CCH₂CH₂ CF₃ CH₃ N≡CCH₂CH₂CH₂ CF₃ CH₃ N≡CCH₂CH₂CH₂CH₂ CF₃ CH₃ H CF₃ CH₃ C₆H₅—CH₂ CF₃ CH₃ 2-F—C₆H₄—CH₂ CF₃ CH₃ 3-F—C₆H₄—CH₂ CF₃ CH₃ 4-F—C₆H₄—CH₂ CF₃ CH₃ 2-Cl—C₆H₄—CH₂ CF₃ CH₃ 3-Cl—C₆H₄—CH₂ CF₃ CH₃ 4-Cl—C₆H₄—CH₂ CF₃ CH₃ 2-Br—C₆H₄—CH₂ CF₃ CH₃ 3-Br—C₆H₄—CH₂ CF₃ CH₃ 4-Br—C₆H₄—CH₂ CF₃ CH₃ 4-I—C₆H₄—CH₂ CF₃ CH₃ 2-CH₃—C₆H₄—CH₂ CF₃ CH₃ 3-CH₃—C₆H₄—CH₂ CF₃ CH₃ 4-CH₃—C₆H₄—CH₂ CF₃ CH₃ 4-CF₃—C₆H₄—CH₂ CF₃ CH₃ 4-CH₃CH₂—C₆H₄—CH₂ CF₃ CH₃ 4-(CH₃)₂CH—C₆H₄—CH₂ CF₃ CH₃ 4-CH₃CH₂CH₂—C₆H₄—CH₂ CF₃ CH₃ 4-(CH₃)₃C—C₆H₄—CH₂ CF₃ CH₃ 2,4-(CH₃)₂—C₆H₃—CH₂ CF₃ CH₃ 2,4,6-(CH₃)₃—C₆H₂—CH₂ CF₃ CH₃ 2,4-Cl₂—C₆H₃—CH₂ CF₃ CH₃ 3,4-Cl₂—C₆H₃—CH₂ CF₃ CH₃ 2,5-Cl₂—C₆H₃—CH₂ CF₃ CH₃ 3,5-Cl₂—C₆H₃—CH₂ CF₃ CH₃ 2,6-Cl₂—C₆H₃—CH₂ CF₃ CH₃ 4-CH₃O—C₆H₄—CH₂ CF₃ CH₃ 4-CF₃O—C₆H₄—CH₂ CF₃ CH₃ 4-CH₃CH₂O—C₆H₄—CH₂ CF₃ CH₃ 4-(CH₃)₂CHO—C₆H₄—CH₂ CF₃ CH₃ 4-(CH₃)₃CO—C₆H₄—CH₂ CF₃ CH₃ 4-CH₃OC(═O)—C₆H₄—CH₂ CF₃ CH₃ 4-CH₃CH₂OC(═O)—C₆H₄—CH₂ CF₃ CH₃ 4-CH₃CH₂CH₂OC(═O)—C₆H₄—CH₂ CF₃ CH₃ 4-(CH₃)₂CHOC(═O)—C₆H₄—CH₂ CF₃ CH₃ 4-(CH₃)₃COC(═O)—C₆H₄—CH₂ CF₃ CH₃ CH₂Cl—CH₂ CF₃ CH₃ CCl≡CCH₂ CF₃ CH₃ CBr≡CCH₂ CF₃ CH₃CH₂ CH₃ CF₃ CH₃CH₂ CH₃CH₂ CF₃ CH₃CH₂ CH₃CH₂CH₂ CF₃ CH₃CH₂ (CH₃)₂CH CF₃ CH₃CH₂ CH₃CH₂CH₂CH₂ CF₃ CH₃CH₂ CH₃CH₂—(CH₃)CH CF₃ CH₃CH₂ (CH₃)₂CHCH₂ CF₃ CH₃CH₂ (CH₃)₃C CF₃ CH₃CH₂ CH₃CH₂CH₂CH₂CH₂ CF₃ CH₃CH₂ (CH₃)₂CHCH₂CH₂ CF₃ CH₃CH₂ (CH₃)₃CCH₂ CF₃ CH₃CH₂ CH₃CH₂CH₂—(CH₃)CH CF₃ CH₃CH₂ (CH₃)₂CH—(CH₃)CH CF₃ CH₃CH₂ CH₃CH₂CH₂CH₂CH₂CH₂ CF₃ CH₃CH₂ CH₂F CF₃ CH₃CH₂ CH₂F—CH₂ CF₃ CH₃CH₂ CF₃CH₂ CF₃ CH₃CH₂ CF₃CH₂CH₂ CF₃ CH₃CH₂ CF₃CH₂CH₂CH₂ CF₃ CH₃CH₂ CF₃CH₂CH₂CH₂CH₂ CF₃ CH₃CH₂ CH₂Cl—CH₂CH₂ CF₃ CH₃CH₂ CH₂Br—CH₂CH₂ CF₃ CH₃CH₂ CH₂Cl—CH₂CH₂CH₂ CF₃ CH₃CH₂ CH₂Br—CH₂CH₂CH₂ CF₃ CH₃CH₂ CH₂Cl—CH₂CH₂CH₂CH₂ CF₃ CH₃CH₂ CH₂Br—CH₂CH₂CH₂CH₂ CF₃ CH₃CH₂ CH₂═CHCH₂ CF₃ CH₃CH₂ CH₂═C(CH₃)—CH₂ CF₃ CH₃CH₂ (CH₃)₂C═CHCH₂ CF₃ CH₃CH₂ CH₃CH═CHCH₂ CF₃ CH₃CH₂ CH₂═CHCH₂CH₂ CF₃ CH₃CH₂ CH₃CH₂CH═CHCH₂ CF₃ CH₃CH₂ CH₃CH═CHCH₂CH₂ CF₃ CH₃CH₂ CH₃CH₂CH₂CH═CHCH₂ CF₃ CH₃CH₂ CH₃CH₂CH═CHCH₂CH₂ CF₃ CH₃CH₂ CHCl═CHCH₂ CF₃ CH₃CH₂ CCl₂═CHCH₂ CF₃ CH₃CH₂ CHBr═CHCH₂ CF₃ CH₃CH₂ CBr₂═CHCH₂ CF₃ CH₃CH₂ CH₂═CClCH₂ CF₃ CH₃CH₂ CH₂═CBrCH₂ CF₃ CH₃CH₂ CH₂═CFCH₂ CF₃ CH₃CH₂ CHCl═CClCH₂ CF₃ CH₃CH₂ CHBr═CBrCH₂ CF₃ CH₃CH₂ CH₃CCl═CHCH₂ CF₃ CH₃CH₂ CF₃CCl═CHCH₂ CF₃ CH₃CH₂ CClH₂—CH═CHCH₂ CF₃ CH₃CH₂ CBrH₂—CH═CHCH₂ CF₃ CH₃CH₂ CF₂═CFCH₂ CF₃ CH₃CH₂ CH≡CCH₂ CF₃ CH₃CH₂ CH₃C≡CCH₂ CF₃ CH₃CH₂ CH₃CH₂C≡CCH₂ CF₃ CH₃CH₂ CH₃C≡CCH₂CH₂ CF₃ CH₃CH₂ CH≡C—(CH₃)CH CF₃ CH₃CH₂ N≡CCH₂ CF₃ CH₃CH₂ N≡CCH₂CH₂ CF₃ CH₃CH₂ N≡CCH₂CH₂CH₂ CF₃ CH₃CH₂ N≡CCH₂CH₂CH₂CH₂ CF₃ CH₃CH₂ H CF₃ CH₃CH₂ C₆H₅—CH₂ CF₃ CH₃CH₂ 2-F—C₆H₄—CH₂ CF₃ CH₃CH₂ 3-F—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-F—C₆H₄—CH₂ CF₃ CH₃CH₂ 2-Cl—C₆H₄—CH₂ CF₃ CH₃CH₂ 3-Cl—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-Cl—C₆H₄—CH₂ CF₃ CH₃CH₂ 2-Br—C₆H₄—CH₂ CF₃ CH₃CH₂ 3-Br—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-Br—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-I—C₆H₄—CH₂ CF₃ CH₃CH₂ 2-CH₃—C₆H₄—CH₂ CF₃ CH₃CH₂ 3-CH₃—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-CH₃—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-CF₃—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-CH₃CH₂—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-(CH₃)₂CH—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-CH₃CH₂CH₂—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-(CH₃)₃C—C₆H₄—CH₂ CF₃ CH₃CH₂ 2,4-(CH₃)₂—C₆H₃—CH₂ CF₃ CH₃CH₂ 2,4,6-(CH₃)₃—C₆H₂—CH₂ CF₃ CH₃CH₂ 2,4-Cl₂—C₆H₃—CH₂ CF₃ CH₃CH₂ 3,4-Cl₂—C₆H₃—CH₂ CF₃ CH₃CH₂ 2,5-Cl₂—C₆H₃—CH₂ CF₃ CH₃CH₂ 3,5-Cl₂—C₆H₃—CH₂ CF₃ CH₃CH₂ 2,6-Cl₂—C₆H₃—CH₂ CF₃ CH₃CH₂ 4-CH₃O—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-CF₃O—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-CH₃CH₂O—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-(CH₃)₂CHO—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-(CH₃)₃CO—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-CH₃OC(═O)—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-CH₃CH₂OC(═O)—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-CH₃CH₂CH₂OC(═O)—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-(CH₃)₂CHOC(═O)—C₆H₄—CH₂ CF₃ CH₃CH₂ 4-(CH₃)₃COC(═O)—C₆H₄—CH₂ CF₃ CH₃CH₂ CH₂Cl—CH₂ CF₃ CH₃CH₂ CCl≡CCH₂ CF₃ CH₃CH₂ CBr≡CCH₂ CF₃ (CH₃)₂CH CH₃ CF₃ (CH₃)₂CH CH₃CH₂ CF₃ (CH₃)₂CH CH₃CH₂CH₂ CF₃ (CH₃)₂CH (CH₃)₂CH CF₃ (CH₃)₂CH CH₃CH₂CH₂CH₂ CF₃ (CH₃)₂CH CH₃CH₂—(CH₃)CH CF₃ (CH₃)₂CH (CH₃)₂CHCH₂ CF₃ (CH₃)₂CH (CH₃)₃C CF₃ (CH₃)₂CH CH₃CH₂CH₂CH₂CH₂ CF₃ (CH₃)₂CH (CH₃)₂CHCH₂CH₂ CF₃ (CH₃)₂CH (CH₃)₃CCH₂ CF₃ (CH₃)₂CH CH₃CH₂CH₂—(CH₃)CH CF₃ (CH₃)₂CH (CH₃)₂CH—(CH₃)CH CF₃ (CH₃)₂CH CH₃CH₂CH₂CH₂CH₂CH₂ CF₃ (CH₃)₂CH CH₂F CF₃ (CH₃)₂CH CH₂F—CH₂ CF₃ (CH₃)₂CH CF₃CH₂ CF₃ (CH₃)₂CH CF₃CH₂CH₂ CF₃ (CH₃)₂CH CF₃CH₂CH₂CH₂ CF₃ (CH₃)₂CH CF₃CH₂CH₂CH₂CH₂ CF₃ (CH₃)₂CH CH₂Cl—CH₂CH₂ CF₃ (CH₃)₂CH CH₂Br—CH₂CH₂ CF₃ (CH₃)₂CH CH₂Cl—CH₂CH₂CH₂ CF₃ (CH₃)₂CH CH₂Br—CH₂CH₂CH₂ CF₃ (CH₃)₂CH CH₂Cl—CH₂CH₂CH₂CH₂ CF₃ (CH₃)₂CH CH₂Br—CH₂CH₂CH₂CH₂ CF₃ (CH₃)₂CH CH₂═CHCH₂ CF₃ (CH₃)₂CH CH₂═C(CH₃)CH₂ CF₃ (CH₃)₂CH (CH₃)₂C═CHCH₂ CF₃ (CH₃)₂CH CH₃CH═CHCH₂ CF₃ (CH₃)₂CH CH₂═CHCH₂CH₂ CF₃ (CH₃)₂CH CH₃CH₂CH═CHCH₂ CF₃ (CH₃)₂CH CH₃CH═CHCH₂CH₂ CF₃ (CH₃)₂CH CH₃CH₂CH₂CH═CHCH₂ CF₃ (CH₃)₂CH CH₃CH₂CH═CHCH₂CH₂ CF₃ (CH₃)₂CH CHCl═CHCH₂ CF₃ (CH₃)₂CH CCl₂═CHCH₂ CF₃ (CH₃)₂CH CHBr═CHCH₂ CF₃ (CH₃)₂CH CBr₂═CHCH₂ CF₃ (CH₃)₂CH CH₂═CClCH₂ CF₃ (CH₃)₂CH CH₂═CBrCH₂ CF₃ (CH₃)₂CH CH₂═CFCH₂ CF₃ (CH₃)₂CH CHCl═CClCH₂ CF₃ (CH₃)₂CH CHBr═CBrCH₂ CF₃ (CH₃)₂CH CH₃CCl═CHCH₂ CF₃ (CH₃)₂CH CF₃CCl═CHCH₂ CF₃ (CH₃)₂CH CClH₂—CH═CHCH₂ CF₃ (CH₃)₂CH CBrH₂—CH═CHCH₂ CF₃ (CH₃)₂CH CF₂═CFCH₂ CF₃ (CH₃)₂CH CH≡CCH₂ CF₃ (CH₃)₂CH CH₃C≡CCH₂ CF₃ (CH₃)₂CH CH₃CH₂C≡CCH₂ CF₃ (CH₃)₂CH CH₃C≡CCH₂CH₂ CF₃ (CH₃)₂CH CH≡C—(CH₃)CH CF₃ (CH₃)₂CH N≡CCH₂ CF₃ (CH₃)₂CH N≡CCH₂CH₂ CF₃ (CH₃)₂CH N≡CCH₂CH₂CH₂ CF₃ (CH₃)₂CH N≡CCH₂CH₂CH₂CH₂ CF₃ (CH₃)₂CH H CF₃ (CH₃)₂CH C₆H₅—CH₂ CF₃ (CH₃)₂CH 2-F—C₆H₄—CH₂ CF₃ (CH₃)₂CH 3-F—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-F—C₆H₄—CH₂ CF₃ (CH₃)₂CH 2-Cl—C₆H₄—CH₂ CF₃ (CH₃)₂CH 3-Cl—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-Cl—C₆H₄—CH₂ CF₃ (CH₃)₂CH 2-Br—C₆H₄—CH₂ CF₃ (CH₃)₂CH 3-Br—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-Br—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-I—C₆H₄—CH₂ CF₃ (CH₃)₂CH 2-CH₃—C₆H₄—CH₂ CF₃ (CH₃)₂CH 3-CH₃—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-CH₃—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-CF₃—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-CH₃CH₂—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-(CH₃)₂CH—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-CH₃CH₂CH₂—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-(CH₃)₃C—C₆H₄—CH₂ CF₃ (CH₃)₂CH 2,4-(CH₃)₂—C₆H₃—CH₂ CF₃ (CH₃)₂CH 2,4,6-(CH₃)₃—C₆H₂—CH₂ CF₃ (CH₃)₂CH 2,4-Cl₂—C₆H₃—CH₂ CF₃ (CH₃)₂CH 3,4-Cl₂—C₆H₃—CH₂ CF₃ (CH₃)₂CH 2,5-Cl₂—C₆H₃—CH₂ CF₃ (CH₃)₂CH 3,5-Cl₂—C₆H₃—CH₂ CF₃ (CH₃)₂CH 2,6-Cl₂—C₆H₃—CH₂ CF₃ (CH₃)₂CH 4-CH₃O—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-CF₃O—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-CH₃CH₂O—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-(CH₃)₂CHO—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-(CH₃)₃CO—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-CH₃OC(═O)—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-CH₃CH₂OC(═O)—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-CH₃CH₂CH₂OC(═O)—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-(CH₃)₂CHOC(═O)—C₆H₄—CH₂ CF₃ (CH₃)₂CH 4-(CH₃)₃COC(═O)—C₆H₄—CH₂ CF₃ (CH₃)₂CH CH₂Cl—CH₂ CF₃ (CH₃)₂CH CCl≡CCH₂ CF₃ (CH₃)₂CH CBr≡CCH₂ CF₃ (CH₃)₃C CH₃ CF₃ (CH₃)₃C CH₃CH₂ CF₃ (CH₃)₃C CH₃CH₂CH₂ CF₃ (CH₃)₃C (CH₃)₂CH CF₃ (CH₃)₃C CH₃CH₂CH₂CH₂ CF₃ (CH₃)₃C CH₃CH₂—(CH₃)CH CF₃ (CH₃)₃C (CH₃)₂CHCH₂ CF₃ (CH₃)₃C (CH₃)₃C CF₃ (CH₃)₃C CH₃CH₂CH₂CH₂CH₂ CF₃ (CH₃)₃C (CH₃)₂CHCH₂CH₂ CF₃ (CH₃)₃C (CH₃)₃CCH₂ CF₃ (CH₃)₃C CH₃CH₂CH₂—(CH₃)CH CF₃ (CH₃)₃C (CH₃)₂CH—(CH₃)CH CF₃ (CH₃)₃C CH₃CH₂CH₂CH₂CH₂CH₂ CF₃ (CH₃)₃C CH₂F CF₃ (CH₃)₃C CH₂F—CH₂ CF₃ (CH₃)₃C CF₃CH₂ CF₃ (CH₃)₃C CF₃CH₂CH₂ CF₃ (CH₃)₃C CF₃CH₂CH₂CH₂ CF₃ (CH₃)₃C CF₃CH₂CH₂CH₂CH₂ CF₃ (CH₃)₃C CH₂Cl—CH₂CH₂ CF₃ (CH₃)₃C CH₂Br—CH₂CH₂ CF₃ (CH₃)₃C CH₂Cl—CH₂CH₂CH₂ CF₃ (CH₃)₃C CH₂Br—CH₂CH₂CH₂ CF₃ (CH₃)₃C CH₂Cl—CH₂CH₂CH₂CH₂ CF₃ (CH₃)₃C CH₂BrCH₂CH₂CH₂CH₂ CF₃ (CH₃)₃C CH₂═CHCH₂ CF₃ (CH₃)₃C CH₂═C(CH₃)—CH₂ CF₃ (CH₃)₃C (CH₃)₂C═CHCH₂ CF₃ (CH₃)₃C CH₃CH═CHCH₂ CF₃ (CH₃)₃C CH₂═CHCH₂CH₂ CF₃ (CH₃)₃C CH₃CH₂CH═CHCH₂ CF₃ (CH₃)₃C CH₃CH═CHCH₂CH₂ CF₃ (CH₃)₃C CH₃CH₂CH₂CH═CHCH₂ CF₃ (CH₃)₃C CH₃CH₂CH═CHCH₂CH₂ CF₃ (CH₃)₃C CHCl═CHCH₂ CF₃ (CH₃)₃C CCl₂═CHCH₂ CF₃ (CH₃)₃C CHBr═CHCH₂ CF₃ (CH₃)₃C CBr₂═CHCH₂ CF₃ (CH₃)₃C CH₂═CClCH₂ CF₃ (CH₃)₃C CH₂═CBrCH₂ CF₃ (CH₃)₃C CH₂═CFCH₂ CF₃ (CH₃)₃C CHCl═CClCH₂ CF₃ (CH₃)₃C CHBr═CBrCH₂ CF₃ (CH₃)₃C CH₃CCl═CHCH₂ CF₃ (CH₃)₃C CF₃CCl═CHCH₂ CF₃ (CH₃)₃C CClH₂CH═CHCH₂ CF₃ (CH₃)₃C CBrH₂CH═CHCH₂ CF₃ (CH₃)₃C CF₂═CFCH₂ CF₃ (CH₃)₃C CH≡CCH₂ CF₃ (CH₃)₃C CH₃C≡CCH₂ CF₃ (CH₃)₃C CH₃CH₂C≡CCH₂ CF₃ (CH₃)₃C CH₃C≡CCH₂CH₂ CF₃ (CH₃)₃C CH≡C—(CH₃)CH CF₃ (CH₃)₃C N≡CCH₂ CF₃ (CH₃)₃C N≡CCH₂CH₂ CF₃ (CH₃)₃C N≡CCH₂CH₂CH₂ CF₃ (CH₃)₃C N≡CCH₂CH₂CH₂CH₂ CF₃ (CH₃)₃C H CF₃ (CH₃)₃C C₆H₅—CH₂ CF₃ (CH₃)₃C 2-F—C₆H₄—CH₂ CF₃ (CH₃)₃C 3-F—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-F—C₆H₄—CH₂ CF₃ (CH₃)₃C 2-Cl—C₆H₄—CH₂ CF₃ (CH₃)₃C 3-Cl—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-Cl—C₆H₄—CH₂ CF₃ (CH₃)₃C 2-Br—C₆H₄—CH₂ CF₃ (CH₃)₃C 3-Br—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-Br—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-I—C₆H₄—CH₂ CF₃ (CH₃)₃C 2-CH₃—C₆H₄—CH₂ CF₃ (CH₃)₃C 3-CH₃—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-CH₃—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-CF₃—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-CH₃CH₂—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-(CH₃)₂CH—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-CH₃CH₂CH₂—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-(CH₃)₃C—C₆H₄—CH₂ CF₃ (CH₃)₃C 2,4-(CH₃)₂—C₆H₃—CH₂ CF₃ (CH₃)₃C 2,4,6-(CH₃)₃—C₆H₂—CH₂ CF₃ (CH₃)₃C 2,4-Cl₂—C₆H₃—CH₂ CF₃ (CH₃)₃C 3,4-Cl₂—C₆H₃—CH₂ CF₃ (CH₃)₃C 2,5-Cl₂—C₆H₃—CH₂ CF₃ (CH₃)₃C 3,5-Cl₂—C₆H₃—CH₂ CF₃ (CH₃)₃C 2,6-Cl₂—C₆H₃—CH₂ CF₃ (CH₃)₃C 4-CH₃O—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-CF₃O—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-CH₃CH₂O—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-(CH₃)₂CHO—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-(CH₃)₃CO—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-CH₃OC(═O)—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-CH₃CH₂OC(═O)—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-CH₃CH₂CH₂OC(═O)—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-(CH₃)₂CHOC(═O)—C₆H₄—CH₂ CF₃ (CH₃)₃C 4-(CH₃)₃COC(═O)—C₆H₄—CH₂ CF₃ (CH₃)₃C CH₂Cl—CH₂ CF₃ (CH₃)₃C CCl≡CCH₂ CF₃ (CH₃)₃C CBr≡CCH₂ (CH₃)₂CH CH₃ H (CH₃)₂CH CH₃ CH₃ (CH₃)₂CH CH₃ CH₃CH₂ (CH₃)₂CH CH₃ CH₃CH₂CH₂ (CH₃)₂CH CH₃ CH₂F (CH₃)₂CH CH₃ CF₃CH₂ (CH₃)₂CH CH₃ CF₃CH₂CH₂ (CH₃)₂CH CH₃ CH₂ClCH₂ (CH₃)₂CH CH₃ CH₂═CHCH₂ (CH₃)₂CH CH₃ CH≡CCH₂ (CH₃)₂CH CH₃ CH₃C≡CCH₂ (CH₃)₂CH CH₃ N≡CCH₂ (CH₃)₃C CH₃ H (CH₃)₃C CH₃ CH₃ (CH₃)₃C CH₃ CH₃CH₂ (CH₃)₃C CH₃ CH₃CH₂CH₂ (CH₃)₃C CH₃ CH₂F (CH₃)₃C CH₃ CF₃CH₂ (CH₃)₃C CH₃ CF₃CH₂CH₂ (CH₃)₃C CH₃ CH₂Cl—CH₂ (CH₃)₃C CH₃ CH₂═CHCH₂ (CH₃)₃C CH₃ CH≡CCH₂ (CH₃)₃C CH₃ CH₃C≡CCH₂ (CH₃)₃C CH₃ N≡CCH₂

TABLE 2 (X represents an oxygen atom) R¹ R² CH₃ CH₃ CH₃ CH₃CH₂ CH₃ (CH₃)₂CH CH₃ (CH₃)₃C CH₃CH₂ CH₃ CH₃CH₂ CH₃CH₂ CH₃CH₂ (CH₃)₂CH CH₃CH₂ (CH₃)₃C CH₃CH₂ CH₃ CH₃CH₂ CH₃CH₂ CH₃CH₂ (CH₃)₂CH CH₃CH₂ (CH₃)₃C (CH₃)₃C CH₃ (CH₃)₃C CH₃CH₂ (CH₃)₃C (CH₃)₂CH (CH₃)₃C (CH₃)₃C (CH₃)₂CH CH₃ (CH₃)₂CH CH₃CH₂ (CH₃)₂CH (CH₃)₂CH (CH₃)₂CH (CH₃)₃C CF₃ CH₃ CF₃ CH₃CH₂ CF₃ (CH₃)₂CH CF₃ (CH₃)₃C The noxious arthropods against which the compound of the present invention has activity may include insect pests and acarine pests, and concretely described below: Hemiptera:

Delphacidae such as Laodelphax striatellus, Nilaparvata lugens, Sogatella furcifera and the like,

Deltocephalidae such as Nephotettix cincticeps, Nephotettix virescens and the like,

Aphididae such as Aphis gossypii, Myzus persicae and the like,

Pentatomidae such as Nezara antennata, Riptortus clavetus and the like,

Aleyrodidae such as Trialeurodes vaporariorum, Bemisia argentifolii and the like,

Coccidae such as Aonidiella aurantii, Comstockaspis perniciosa, Unaspis citri, Ceroplastes rubens, Icerya purchasi and the like,

Tingidae,

Psyllidae, and the like;

Lepidoptera:

Pyralidae such as Chilo suppressalis, Cnaphalocrocis medinalis, Notarcha derogata, Plodia interpunctella and the like,

Noctuidae such as Spodoptera litura, Pseudaletia separata, Thoricoplusia spp., Heliothis spp., Helicoverpa spp. and the like,

Pieridae such as Pieris rapae and the like,

Tortricidae such as Adoxophyes spp., Grapholita molesta, Cydia pomonella and the like,

Carposinidae such as Carposina niponensis and the like,

Lyonetiidae such as Lyonetia spp. and the like,

Lymantriidae such as Lymantria spp., Euproctis spp., and the like,

Yponomeutidae such as Plutella xylostella and the like,

Gelechiidae such as Pectinophora gossypiella and the like,

Arctiidae such as Hyphantria cunea and the like,

Tineidae such as Tinea translucens, Tineola bisselliella and the like;

Diptera:

Calicidae such as Culex pipiens pallens, Culex tritaeniorhynchus, Culex quinquefasciatus and the like,

Aedes spp. such as Aedes aegypti, Aedes albopictus and the like,

Anopheles such as Anopheles sinensis and the like,

Chironomidae,

Muscidae such as Musca domestica, Muscina stabulans and the like,

Calliphoridae,

Sarcophagidae,

Fanniidae,

Anthomyiidae such as Delia platura, Delia antiqua and the like,

Tephritidae,

Drosophilidae,

Psychodidae,

Tabanidae,

Simuliidae,

Stomoxyidae,

Agromyzidae, and the like;

Coleoptera:

Diabrotica spp. such as Diabrotica virgifera virgifera, Diabrotica undecimpunctata howardi and the like,

Scarabaeidae such as Anomala cuprea, Anomala rufocuprea and the like,

Curculionidae such as Sitophilus zeamais, Lissorhoptrus oryzophilus, Callosobruchuys chienensis and the like,

Tenebrionidae such as Tenebrio molitor, Tribolium castaneum and the like,

Chrysomelidae such as Aulacophora femoralis, Phyllotreta striolata, Leptinotarsa decemlineata and the like,

Anobiidae,

Epilachna spp. such as Epilachna vigintioctopunctata and the like,

Lyctidae,

Bostrychidae,

Cerambycidae,

Paederus fuscipes;

Blattodea:

Blattella germanica, Periplaneta fulginosa, Periplaneta americana, Periplaneta brunnea, Blatta orientalis and the like;

Thysanoptera:

Thrips palmi, Thrips tahaci, Frankliniella occidentalis and the like;

Hymenoptera:

Formicidae such as Monomorium pharaonis, Vespidae, bethylid wasp, Tenthredinidae such as Athalia japonica, and the like;

Orthoptera:

Gryllotalpidae, Acrididae, and the like;

Aphaniptera:

Ctenocephalides felis, Ctenocephalides canis, Pulex irritans, Xenopsylla cheopis, and the like;

Anoplura:

Pediculus humanus corporis, Phthirus pubis, Haematopinus eurysternus, Dalmalinia ovis, and the like;

Isoptera:

Reticulitermes speratus, Coptotermes formosanus, and the like;

Acarina:

Tetranychidae such as Tetranychus urticae, Panonychus citri, Oligonychus spp., and the like,

Eriophyidae such as Aculops pelekassi and the like,

Tarsonemidae such as Polyphagotarsonemus latus, and the like,

Tenuipalpidae,

Tuckerellidae,

Ixodidae such as Haemaphysalis longicornis, Haemaphysalis flava, Dermacentor taiwanicus, Ixodes ovatus, Ixodes persulcatus, Boophilus microplus, Rhipicephalus sanguineus, and the like,

Acaridae such as Tyrophagus putrescentiae, and the like,

Epidermoptidae such as Dermatophagoides farinae, Dermatophagoides ptrenyssnus, and the like,

Cheyletidae such as Cheyletus eruditus, Cheyletus malaccensis, Cheyletus moorei, and the like,

Dermanyssidae.

The noxious arthropods controlling composition of the present invention contains the compound of the present invention and an inert carrier. Generally, it is a preparation obtained by mixing the compound of the present invention and a solid carrier, a liquid carrier, a gaseous carrier and/or bait for poison bait, and if necessary, adding a surfactant and other adjuvant for formulation. The formulation includes an oil solution, an emulsion, a flowable formulation, a wettable powder, a granule, a powder, a microcapsule, and the like. These formulations can be converted to use into a poison bait, a sheet. In the noxious arthropods controlling composition of the present invention, the compound of the present invention is usually contained in an amount of 0.01% to 95% by weight.

The solid carrier for formulation includes, for example, a fine power and a granule of clays (e.g., kaolin clay, diatomite, bentonite, Fubasami clay, acid clay, etc.), synthetic hydrated silicon oxide, talc, ceramic, other inorganic minerals (e.g., sericite, quartz, sulfur, activated carbon, calcium carbonate, hydrated silica) or chemical fertilizers (e.g., ammonium sulfate, ammonium phosphate, ammonium nitrate, urea, ammonium chloride).

The liquid carrier for formulation includes, for example, water, alcohols (e.g., methanol, ethanol, isopropyl alcohol, butanol, hexanol, benzyl alcohol, ethylene glycol, propylene glycol, phenoxyethanol), ketones (e.g., acetone, methyl ethyl ketone, cyclohexanone), aromatic hydrocarbons (e.g., toluene, xylene, ethylbenzen, dodecylbenzen, phenylxylylethane, methylnaphthalene), aliphatic hydrocarbons (e.g., hexane, cyclohexane, kerosine, light oil), esters (e.g., ethyl acetate, butyl acetate, isopropyl mylistate, ethyl oleate, diisopropyl adipate, diisobutyl adipate, propyleneglycol monomethyl ether acetate), nitriles (e.g., acetonitrile, isobutyronitrile), ethers (e.g., diisopropyl ether, 1,4-dioxane, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, diethylene glycol monomethyl ether, propylene glycol monomethyl ether, dipropylene glycol monomethylether, 3-methoxy-3-methyl-1-butanol), acid amides (e.g., N,N-dimethylformamide, N,N-dimethylacetamide), halogenated hydrocarbons (e.g., dichloromethane, trichloroethane, carbontetrachloride), sulfoxides (e.g., dimethylsulfoxide), and vegetable oils (e.g., soy bean oil, cotton seed oil).

The gaseous carrier for formulation includes, for example, fluorocarbons, butane gas, liquefied petroleum gas (LPG), dimethyl ether, and carbon dioxide.

The surfactant for formulation includes, for example, non-ionic surfactant, such as polyoxyethylene alkyl ether, polyoxyethylene alkylaryl ether, polyethyleneglycol fatty acid ester; anionic surfactant, such as alkylsulfonic acid salts, alkylbenzenesulfonic acid salts, alkylsurfic acid salts.

The other adjuvant for formulation includes, for example, binders, dispersants and stabilizers, and specifically for example, casein, gelatin, polysaccharides (e.g., starch, gum arabic, cellulose derivatives, alginic acid), lignin derivatives, bentonite, synthetic water-soluble polymers (e.g., polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acid), PAP (isopropyl acid phosphate), BHT (2,6-di-t-butyl-4-methylphenol), BHA (a mixture of 2-t-butyl-4-methoxyphenol and 3-t-butyl-4-methoxyphenol).

The method for controlling noxious arthropods of the present invention is applying the compound of the present invention to arthropods directly and/or habitats of arthropods (e.g., plant, soil, indoor, in-body of animals, and so on). The compound of the present invention is usually used as the noxious arthropods controlling composition.

When the noxious arthropods controlling composition of the present invention is used for a control of arthropods in agriculture and forestry, the application amount is usually 1 to 10,000 g as the compound of the present invention per 10,000 m². The emulsions, wettable powders and flowable formulations of the noxious arthropods controlling composition of the present invention are usually applied after dilution with water to have an active ingredient concentration of 0.01 to 10,000 ppm, while powders and granules are usually applied as such.

These preparations and the dilutions of the preparation may be sprayed directly to arthropods or the plants to be protected from arthropods. The arthropods living in a soil can be controlled by treating the soil with these preparations.

Furthermore, the reginous preparations processed to sheets or strip form can be applied by a method such as winding around plants, stretching in the vicinity of plants and laying on the soil surface at the plant bottom.

When the noxious arthropods controlling composition of the present invention is used for a control of noxious arthropods in indoor (e.g., fly, mesquite, cockroach), the application amount is usually 0.01 to 1,000 mg as the compound of the present invention per 1 m² in case of application for plane surface, and 0.01 to 500 mg as the compound of the present invention per 1 m³ in case of application for space. The emulsions, wettable powders and flowable formulations are usually applied after dilution with water to have an active ingredient concentration of 0.1 to 1,000 ppm, while oil solutions, aerosols, smoking agents and poison baits are usually applied as such.

The noxious arthropods controlling composition of the present invention can contain other noxious arthropods controlling compositions, nematocides, fungicides, herbicides, plant growth regulators, synergists, fertilizers, soil conditioners, animal feeds, and the like.

The active ingredients of noxious arthropods controlling composition and nematocides include, for example, organophosphorus compounds such as Fenitrothion, Fenthion, Pyridaphenthion, Diazinon, Chlorpyriphos, Chlorpyriphos-methyl, Acephate, Methidathion, Disulfoton, DDVP, Sulprofos, Cyanophos, Dioxabenzofos, Dimethoate, Phenthoate, Malathion, Trichlorfon, Azinphos-methyl, Monocrotophos Ethion Profenofos, Methyl-parathion, and Isoxathion; carbamate compounds such as BPMC, Benfuracarb, Propoxur, Carbosulfan, Carbaril, Methomyl, Ethiofencarb, Aldicarb, Oxamyl, Fenothiocarb, Thiodicarb, and Alanycarb; pyrethroid compounds such as Etofenprox, Fenvalerate, Esfenvalerate, Fenpropathrin, Cypermethrin, alfa-Cypermethrin, zeta-Cypermethrin, Permethrin, Cyhalothrin, lambda-Cyhalothrin, delta-Cyhalothrin, Cyfluthrin, beta-Cyfluthrin, Cycloprothrin, Fluvalinate, Flucythrinate, Bifenthrin, Acrinathrin, Traromethrin and Silafluofen; neonicotinoid compounds such as Acetamiprid, Nitenpyram, Thiamethoxiam and Thialoprid; Nereistoxin derivatives such as Cartap, Thiocyclam, and Bensultap; chlorinated hydrocarbon compounds such as Endosulfan, gamma-BHC, and 1,1-bis(chlorophenyl)-2,2,2-trichloroethanol; benzoylphenylurea compounds such as Chlorfluazuron, Teflubenzuron, Fulphenoxron, and Lufenuron; phenylhydrazide compounds such as Tebufenozide, Chromafenozide, Methoxyfenozide and Halofenozide; formamidine derivatives such as Amitraz and Chlordimeform; thiourea derivatives such as Diafenthiuron; Buprofezin; Chlorfenapyr; Spinosad and derivatives thereof, Emamectin benzoate; Indoxacarb; Pymetrozine; phenylpyrazole derivatives; Bromopropylate; Tetradifon; Chinomethionat; Propargite; Fenbutatin oxide; Cyhexatin; Hexathiazox; Clofentezine; Pyridaben; Fenpyroximate; Tebufenpyrad; Pyrimidifen; Fenazaquin; Bifenazate; Acequinocyl; Spirodiclofen; Spiromesifen; polynactin complexes [e.g., tetranactin, dinactin, trinactin]; Milbemectin; Avermectin; Azadilactin.

The present invention will be further illustrated by the following production examples, formulation examples, and test examples; however, the present invention is not limited to these examples.

The following describes the production examples for the present compounds.

PRODUCTION EXAMPLE 1

200 mg of the compound of formula (i):

was dissolved in 3 ml of N,N-dimethylformamide, 100 mg of potassium carbonate and 100 mg of 1,1,3-trichloropropene were added to the mixture, and the mixture was stirred at 70° C. for one hour. The reaction mixture was cooled to room temperature, water and 10% hydrochloric acid were added thereto, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 190 mg of the compound of formula (1):

(hereinafter, referred as the present compound (1)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 9.51 (1H, s), 6.83-6.97 (8H, m), 6.16 (1H, t), 4.64 (2H, d), 3.66 (3H, s), 2.45 (3H, s)

PRODUCTION EXAMPLE 2

440 mg of the compound of formula (ii):

was dissolved in 5 ml of N,N-dimethylformamide, 220 mg of potassium carbonate and 210 mg of 1,1,3-trichloropropene were added to the mixture, and the mixture was stirred at 70° C. for one hour. The reaction mixture was cooled to room temperature, water and 10% hydrochloric acid were added thereto, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 480 mg of the compound of formula (2):

(hereinafter, referred as the present compound (2)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 9.53 (1H, s), 6.86-6.98 (8H, m), 6.16 (1H, t), 3.66 (3H, s), 2.85 (2H, q), 1.26 (3H, t)

PRODUCTION EXAMPLE 3

200 mg of the present compound (1) was dissolved in 5 ml of pyridine, 45 mg of methoxyamine hydrochloric acid salt was added to the mixture under ice-cooling, and the mixture was stirred at room temperature for two hours. The reaction mixture was concentrated under reduced pressure. Water and 10% hydrochloric acid were added to the residue, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 200 mg of the compound of formula (3):

(hereinafter, referred as the present compound (3)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.74 (1H, s), 6.16-6.96 (8H, m), 6.16 (1H, t), 4.64 (2H, d), 3.81 (3H, s), 3.62 (3H, s), 2.38 (3H, s)

PRODUCTION EXAMPLE 4

By using 50 mg of ethoxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained i70 mg of the compound of formula (4):

(hereinafter, referred as the present compound (4)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.75 (1H, s), 6.83-6.95 (8H, m), 6.15 (1H, t), 4.63 (2H, d), 4.04 (2H, q), 3.61 (3H, s), 2.37 (3H, s), 1.21 (3H, t)

PRODUCTION EXAMPLE 5

By using 62 mg of isopropoxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 140 mg of the compound of formula (5):

(hereinafter, referred as the present compound (5)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.77 (1H, s), 6.82-6.98 (8H, m), 6.15 (1H, t), 5.37 (1H, q), 4.63 (2H, d), 3.61 (3H, s), 2.37 (3H, s), 1.73 (6H, d)

PRODUCTION EXAMPLE 6

By using 248 mg the present compound (1) and 80 mg of tert-butoxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 270 mg of the compound of formula (6):

(hereinafter, referred as the present compound (6)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.76 (1H, s), 6.82-6.99 (8H, m), 6.16 (1H, t), 4.63 (2H, d), 3.62 (3H, s), 2.38 (3H, s), 1.21 (9H, s)

PRODUCTION EXAMPLE 7

By using 77 mg of pentyloxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 130 mg of the compound of formula (7):

(hereinafter, referred as the present compound (7)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.76 (1H, s), 6.83-6.95 (8H, m), 6.16 (1H, t), 4.64 (2H, d), 3.98 (2H, t), 3.61 (3H, s), 2.37 (3H, s), 1.58 (2H, br), 1.30-1.32 (5H, m), 0.89 (3H, t)

PRODUCTION EXAMPLE 8

By using 60 mg of 2-propynyloxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 140 mg of the compound of formula (8):

(hereinafter, referred as the present compound (8)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.80 (1H, s), 6.84-6.96 (8H, m), 6.16 (1H, t), 4.64 (2H, d), 4.60 (1H, s), 3.62 (3H, s), 2.44 (3H, s)

PRODUCTION EXAMPLE 9

By using 55 mg of allyloxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 200 mg of the compound of formula (9):

(hereinafter, referred as the present compound (9)).

1H-NMR (CDCl₃, TMS) δ (ppm): 7.79 (1H, s), 6.83-6.95 (8H, m), 6.15 (1H, t), 5.90-5.97 (1H, m), 5.16-5.28 (2H, m), 4.64 (2H, d), 4.50 (2H, d), 3.61 (3H, s)

PRODUCTION EXAMPLE 10

By using 100 mg of 3,3-dichloro-2-propenyloxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 130 mg of the compound of formula (10):

(hereinafter, referred as the present compound (10)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.75 (1H, s), 6.83-6.95 (8H, m), 6.15 (1H, t), 6.03 (1H, t), 4.64 (2H, d), 4.57 (2H, d), 3.62 (3H, s), 2.36 (3H, s)

PRODUCTION EXAMPLE 11

By using 75 mg of benzyloxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 165 mg of the compound of formula (11):

(hereinafter, referred as the present compound (11)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.80 (1H, s), 7.28-7.32 (5H, m), 6.81-6.95 (8H, m), 6.16 (1H, t), 5.02 (2H, s), 4.63 (2H, d), 3.60 (3H, s), 2.35 (3H, s)

PRODUCTION EXAMPLE 12

By using 55 mg of (E)-2-butenyloxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 90 mg of the compound of formula (12):

(hereinafter, referred as the present compound (12)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.77 (1H, s), 6.83-6.96 (8H, m), 6.16 (1H, t), 5.60-6.17 (2H, m), 4.64 (2H, d), 4.42 (2H, d), 3.62 (3H, s), 2.37 (3H, q) 1.71 (3H, d)

PRODUCTION EXAMPLE 13

190 mg of the present compound (2) was dissolved in 5 ml of pyridine, 43 mg of methoxyamine hydrochloric acid salt was added to the mixture under ice-cooling, and the mixture was stirred at room temperature for two hours. The reaction mixture was concentrated under reduced pressure. Water and 10% hydrochloric acid were added to the residue, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 150 mg of the compound of formula (13):

(hereinafter, referred as the present compound (13)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.74 (1H, s), 6.83-6.95 (8H, m), 6.16 (1H, t), 4.64 (2H, d), 3.80 (3H, s), 3.62 (3H, s), 2.78 (2H, q), 1.27 (3H, t)

PRODUCTION EXAMPLE 14

By using 180 mg of the present compound (2) and 50 mg of ethoxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 160 mg of the compound of formula (14):

(hereinafter, referred as the present compound (14)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.77 (1H, s), 6.83-6.95 (8H, m), 6.16 (1H, t), 4.64 (2H, d), 4.04 (2H, q), 3.62 (3H, s), 2.77 (2H, q), 1.19-1.28 (6H, m)

PRODUCTION EXAMPLE 15

190 mg of the compound of formula (iii):

was dissolved in 2 ml of N,N-dimethylformamide, 80 mg of potassium carbonate and 80 mg of 1,1,3-trichloropropene were added to the mixture, and the mixture was stirred at 80° C. for one hour. The reaction mixture was cooled to room temperature, water and 10% hydrochloric acid were added thereto, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 150 mg of the compound of formula (15):

(hereinafter, referred as the present compound (15)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.84 (1H, s), 6.85-6.95 (8H, m), 6.16 (1H, t), 4.64 (2H, d), 3.78 (3H, s), 3.71 (3H, s)

PRODUCTION EXAMPLE 16

170 mg of the compound of the formula (iv):

was dissolved in 3 ml of N,N-dimethylformamide, 80 mg of potassium carbonate and 70 mg of 1, 3-dichloro-2-butene were added to the mixture, and the mixture was stirred at 80° C. for one hour. The reaction mixture was cooled to room temperature, water and 10% hydrochloric acid were added thereto, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 160 mg of the compound of formula (16):

(hereinafter, referred as the present compound (16)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.73 (1H, s), 6.82-6.96 (8H, m), 5.76 (1H, t), 4.66 (2H, d), 4.48 (3H, s), 3.61 (3H, s), 2.38 (3H, s), 2.17 (3H, s)

PRODUCTION EXAMPLE 17

By using 60 mg of 1,3-dichloropropene instead of 1,3-dichloro-2-butene according to Production Example 16 was obtained 130 mg of the compound of formula (17):

(hereinafter, referred as the present compound (17)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.74 (1H, s), 6.83-6.95 (8H, m), 6.37-6.40 (1H, m), 6.13-6.19 (1H, m), 4.50 (2H, d), 3.80 (3H, s), 3.61 (3H, s), 2.38 (3H, s)

PRODUCTION EXAMPLE 18

114 mg of the present compound (1) was dissolved in 3 ml of pyridine, 25 mg of hydroxylamine hydrochloric acid salt was added to the mixture under ice-cooling, and the mixture was stirred at room temperature for thirty minutes. The reaction mixture was concentrated under reduced pressure. Water and 10% hydrochloric acid were added to the residue, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 80 mg of the compound of formula (18):

(hereinafter, referred as the present compound (18)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.83 (1H, s), 7.08 (1H, s), 6.84-6.96 (8H, m), 6.16 (1H, t), 4.64 (2H, d), 3.61 (3H, s), 2.36 (3H, s)

PRODUCTION EXAMPLE 19

By using 370 mg of the present compound (1) and 110 mg of propoxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 400 mg of the compound of formula (19):

(hereinafter, referred as the present compound (19)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 0.90 (3H, t), 1.61 (2H, m), 2.37 (3H, s), 3.62 (3H, s), 3.94 (2H, t), 4.64 (2H, d), 6.16 (1H, t), 6.83-6.96 (8H, m), 7.77 (1H, s)

PRODUCTION EXAMPLE 20

By using 150 mg of the present compound (1) and 60 mg of neopentyloxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 130 mg of the compound of formula (20):

(hereinafter, referred as the present compound (20)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 0.90 (6H, d), 1.46-1.70 (3H, m), 2.37 (3H, s), 3.61 (3H, s), 4.02 (2H, t), 4.64 (2H, d), 6.16 (1H, t), 6.82-6.96 (8H, m), 7.75 (1H, s)

PRODUCTION EXAMPLE 21

By using 150 mg of the present compound (1) and 60 mg of 3-methyl-2-butenyloxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 150 mg of the compound of formula (21):

(hereinafter, referred as the present compound (21)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 1.70 (3H, s), 1.75 (3H, s), 2.37 (3H, s), 3.61 (3H, s), 4.50 (2H, d), 4.63 (2H, d), 5.38 (1H, m), 6.16 (1H, t), 6.82-6.96 (8H, m), 7.77 (1H, s)

PRODUCTION EXAMPLE 22

By using 150 mg of the present compound (1) and 50 mg of 1-methyl-2-propynyloxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 110 mg of the compound of formula (22):

(hereinafter, referred as the present compound (22)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 1.46 (3H, d), 2.38 (3H, s), 2.43 (1H, d), 3.62 (3H, s), 4.63 (2H, d), 4.79 (1H, m), 6.16 (1H, t), 6.83-6.96 (8H, m), 7.79 (1H, s)

PRODUCTION EXAMPLE 23

By using 150 mg of the present compound (1) and 50 mg of 1-methylpropoxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 170 mg of the compound of formula (23):

(hereinafter, referred as the present compound (23)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 0.88 (3H, t), 1.15 (3H, d), 1.41-1.64 (2H, m), 2.37 (3H, s), 3.62 (3H, s), 4.04 (1H, m), 4.63 (2H, d), 6.16 (1H, t) 6.83-6.96 (8H, m), 7.76 (1H, s)

PRODUCTION EXAMPLE 24

By using 150 mg of the present compound (1) and 70 mg of 1,2-dimethylpropoxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 160 mg of the compound of formula (24):

(hereinafter, referred as the present compound (24)).

¹H-NMR (CDCl₃, TMS) o (ppm): 0.83 (3H, d), 0.88 (3H, d), 1.11 (3H, d), 1.82 (1H, m), 2.37 (3H, s), 3.62 (3H, s), 3.89 (1H, m), 4.64 (2H, d), 6.16 (1H, t), 6.82-6.96 (8H, m), 7.76 (1H, s)

PRODUCTION EXAMPLE 25

By using 150 mg of the present compound (1) and 50 mg of 2-fluoroethoxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 130 mg of the compound of formula (25):

(hereinafter, referred as the present compound (25)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 2.36 (3H, s), 3.62 (3H, s), 4.21 (2H, dt), 4.56 (2H, dt), 4.64 (2H, d), 6.16 (1H, t), 6.82-6.97 (8H, m), 7.83 (1H, s)

PRODUCTION EXAMPLE 26

By using 150 mg of the present compound (1) and 70 mg of 3,3,3-trifluoropropoxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 140 mg of the compound of formula (26):

(hereinafter, referred as the present compound (26)).

¹H-NMR (CDCl₃, TMS) o (ppm): 2.36 (5H, m), 3.63 (3H, s), 4.19 (2H, t), 4.64 (2H, d), 6.16 (1H, t), 6.83-6.96 (8H, m), 7.77 (1H, s)

PRODUCTION EXAMPLE 27

By using 150 mg of the present compound (1) and 70 mg of 4,4,4-trifluorobutoxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 120 mg of the compound of formula (27):

(hereinafter, referred as the present compound (27)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 1.86 (2H, m), 2.12 (2H, m), 2.36 (3H, s), 3.62 (3H, s), 4.03 (2H, t), 4.64 (2H, d), 6.16 (1H, t), 6.82-6.96 (8H, m) 7.77 (1H, s)

PRODUCTION EXAMPLE 28

By using 150 mg of the present compound (1) and 70 mg of 3-chloro-2-propenyloxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 160 mg of the compound of formula (28):

(hereinafter, referred as the present compound (28)) as the mixture of diastereomers.

¹H-NMR (CDCl₃, TMS) δ (ppm): 2.36 (1.5H, s), 2.36 (1.5H, s), 3.62 (3H, s), 4.45 (1H, dd), 4.64 (2H, d), 4.70 (1H, dd), 5.94 (0.5H, m), 6.04 (0.5H, m), 6.16 (2H, m), 6.83-6.96 (8H, m), 7.76 (0.5H, s), 7.77 (0.5H, s)

PRODUCTION EXAMPLE 29

By using 150 mg of the present compound (1) and 110 mg of 3,3-dibromo-2-propenyloxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 220 mg of the compound of formula (29):

(hereinafter, referred as the present compound (29)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 2.36 (3H, s), 3.62 (3H, s), 4.48 (2H, d), 4.64 (2H, d), 6.16 (1H, t), 6.59 (1H, t), 6.83-6.97 (8H, m), 7.76 (1H, s)

PRODUCTION EXAMPLE 30

By using 150 mg of the present compound (1) and 60 mg of butoxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 160 mg of the compound of formula (30):

(hereinafter, referred as the present compound (30)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 0.91 (3H, t), 1.35 (2H, m), 1.56 (2H, m), 2.37 (3H, s), 3.62 (3H, s), 4.00 (2H, t), 4.64 (2H, d), 6.16 (1H, t), 6.82-6.96 (8H, m), 7.76 (1H, s)

PRODUCTION EXAMPLE 31

200 mg of the present compound (18) was dissolved in 2 ml of N,N-dimethylformamide, 120 mg of potassium carbonate and 110 mg of bromoacetonitrile were added to the mixture, and the mixture was stirred at 40° C. for five hours. The reaction mixture was cooled to room temperature, the reaction mixture added to dilute hydrochloric acid, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 80 mg of the compound of formula (31):

(hereinafter, referred as the present compound (31)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 2.38 (3H, s), 3.63 (3H, s), 4.63 (4H, m), 6.16 (1H, t), 6.85-6.98 (8H, m), 7.82 (1H, s)

PRODUCTION EXAMPLE 32

By using 3.50 g of the present compound (1) and 1.35 g of 2,2,2-trifluoroethoxyamine hydrochloric acid salt instead of methoxyamine hydrochloric acid salt according to Production Example 3 was obtained 3.85 g of the compound of formula (32):

(hereinafter, referred as the present compound (32)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 2.36 (3H, s), 3.62 (3H, s), 4.34 (2H, q), 4.64 (2H, d), 6.16 (1H, t), 6.82-6.97 (8H, m), 7.83 (1H, s)

PRODUCTION EXAMPLE 33

150 mg of the present compound (18) was dissolved in 2 ml of N,N-dimethylformamide, 90 mg of potassium carbonate and 90 mg of 1-bromo-2-methylpropane were added to the mixture, and the mixture was stirred at 70° C. for ten hours. The reaction mixture was cooled to room temperature, the reaction mixture was added to dilute hydrochloric acid, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 40 mg of the compound of formula (33):

(hereinafter, referred as the present compound (33)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 0.88 (6H, d), 1.90 (1H, m), 2.37 (3H, s), 3.62 (3H, s), 3.76 (2H, d), 4.64 (2H, d), 6.16 (1H, t), 6.83-6.96 (8H, m) 7.77 (1H, s)

PRODUCTION EXAMPLE 34

90 mg of sodium hydride (60% oil suspension) was suspended in 5 ml of hexane, and 460 mg of 5-chloro-1,3-dimethyl-1H-pyrazole-4-carbaldehyde was added to the mixture at room temperature. Afterward 500 mg of the compound of formula (v):

was added dropwise to the mixture under reflux condition, and the mixture was stirred five hours under reflux condition. Saturated ammonium chloride aqueous solution was added to the reaction mixture, and extracted with ethyl acetate. The organic layer was washed with dilute hydrochloric acid, water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 260 mg of the compound of the formula (34):

(hereinafter, referred as the present compound (34)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 2.45 (3H, s), 3.65 (3H, s), 4.64 (2H, d), 6.15 (1H, t), 6.78-7.01 (7H, m), 9.51 (1H, s)

PRODUCTION EXAMPLE 35

150 mg of the present compound (34) was dissolved in 2 ml of pyridine, 40 mg of 2-propynyloxyamine hydrochloric acid salt was added to the mixture under ice-cooling, and the mixture was stirred at room temperature for five hours. The reaction mixture was concentrated under reduced pressure. Dilute hydrochloric acid were added to the residue, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 150 mg of the compound of formula (35):

(hereinafter, referred as the present compound (35)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 2.36 (3H, s), 2.43 (1H, t), 3.62 (3H, s), 4.59 (2H, d), 4.63 (2H, d), 6.15 (1H, t), 6.76-7.01 (7H, m), 7.80 (1H, s)

PRODUCTION EXAMPLE 36

200 mg of the present compound (18) was dissolved in 2 ml of N,N-dimethylformamide, 80 mg of potassium carbonate and 60 mg of 2,3-dichloropropene were added to the mixture at room temperature, and the mixture was stirred at 70° C. for ten hours. The reaction mixture was cooled to room temperature, added to dilute hydrochloric acid, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 130 mg of the compound of formula (36):

(hereinafter, referred as the present compound (36)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 2.35 (3H, s), 3.62 (3H, s), 4.52 (2H, s), 4.64 (2H, d), 5.33 (1H, s), 5, 35 (1H, s), 6.16 (1H, t), 6.82-6.97 (8H, m), 7.84 (1H, s)

PRODUCTION EXAMPLE 37

200 mg of the present compound (18) was dissolved in 2 ml of N,N-dimethylformamide, 90 mg of potassium carbonate and 110 mg of 2-chloroethyl methansulfonate were added to the mixture at room temperature, and the mixture was stirred at 70° C. for ten hours. The reaction mixture was cooled to room temperature, added to dilute hydrochloric acid, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 90 mg of the compound of formula (37):

(hereinafter, referred as the present compound (37)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 2.35 (3H, s), 3.60 (2H, t), 3.63 (3H, s), 4.18 (2H, t), 4.64 (2H, d), 6.16 (1H, t), 6.83-6.98 (8H, m), 7.82 (1H, s)

PRODUCTION EXAMPLE 38

270 mg of the compound of the formula (vi):

was dissolved in 2 ml of N,N-dimethylformamide, 150 mg of potassium carbonate and 140 mg of 1,1,3-trichloropropene were added to the mixture, and the mixture was stirred at room temperature for ten hours. The reaction mixture was cooled, added to dilute hydrochloric acid, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 350 mg of the compound of formula (38):

(hereinafter, referred as the present compound (38)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 2.25 (3H, s), 2.47 (3H, s), 3.57 (3H, s), 4.64 (2H, d), 6.16 (1H, t), 6.81-6.97 (8H, m)

PRODUCTION EXAMPLE 39

160 mg of the present compound (38) was dissolved in 2 ml of pyridine, 50 mg of 2-propynyloxyamine hydrochloric acid salt was added to the mixture at room temperature, and the mixture was stirred at room temperature for ten hours. The reaction mixture was concentrated under reduced pressure. Dilute hydrochloric acid were added to the residue, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 170 mg of the compound of formula (39):

(hereinafter, referred as the present compound (39)).

¹H-NMR (CDCl₃, TMS) 8 (ppm): 2.00 (3H, s), 2.39 (3H, s), 2.43 (1H, t), 3.58 (3H, s), 4.64 (2H, d), 4.65 (2H, d), 6.16 (1H, t), 6.77-6.97 (8H, m)

PRODUCTION EXAMPLE 40

300 mg of the present compound (18) was dissolved in 3 ml of N,N-dimethylformamide, 100 mg of potassium carbonate and 110 mg of 1-bromo-2-butyne were added to the mixture at room temperature, and the mixture was stirred at 40° C. for ten hours. The reaction mixture was cooled to room temperature, added to dilute hydrochloric acid, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 250 mg of the compound of formula (40):

(hereinafter, referred as the present compound (40)).

¹H-NMR (CDCl₃, TMS) δ (ppm): 1.85 (3H, t), 2.37 (3H, s), 3.62 (3H, s), 4.57 (2H, q), 4.64 (2H, d), 6.16 (1H, t), 6.83-6.97 (8H, m), 7.79 (1H, s)

Next, the following describes the reference production examples for the intermediates of the present invention

REFERENCE PRODUCTION EXAMPLE 1

330 mg of the compound of formula (i) was dissolved in 3 ml of pyridine, 100 mg of methoxyamine hydrochloric acid salt was added thereto at ice-cooling, and the mixture was stirred at room temperature for two hours. The reaction mixture was concentrated under reduced pressure. Water and 10% hydrochloric acid were added to the residue, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 290 mg of the compound of formula (iv).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.74 (1H, s), 6.80-6.90 (8H, m), 5.97 (1H, s), 3.81 (3H, s), 3.61 (3H, s), 2.39 (3H, s)

REFERENCE PRODUCTION EXAMPLE 2

240 mg of the compound of formula (vii)

was dissolved in 3 ml of pyridine, 64 mg of methoxyamine hydrochloric acid salt was added thereto at ice-cooling, and the mixture was stirred at room temperature for two hours. The reaction mixture was concentrated under reduced pressure. Water and 10% hydrochloric acid were added to the residue, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 260 mg of the compound of formula (iii).

¹H-NMR (CDCl₃, TMS) δ (ppm): 7.83 (1H, s), 6.79-7.11 (8H, m), 5.28 (1H, br), 3.78 (3H, s), 3.70 (3H, s)

REFERENCE PRODUCTION EXAMPLE 3

300 mg of 4,4′-dihydroxydiphenyl ether was dissolved in 5 ml of N,N-dimethylformamide, 120 mg of sodium hydride (60% oil suspension) was added thereto under ice-cooling, the mixture was stirred at room temperature for ten minutes. Afterward, 230 mg of 5-chloro-1,3-dimethyl-1H-pyrazole-4-carboaldehyde in 3 ml of N,N-dimethylformamide was added dropwise at 70° C. under stirring over ten minutes, stirred at 70° C. for two hours. The reaction mixture was cooled to room temperature, water and 10% hydrochloric acid were added thereto, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 260 mg of the compound of formula (i).

¹H-NMR (CDCl₃, TMS) δ (ppm): 9.50 (1H, s), 6.76-6.99 (8H, m), 5.44 (1H, br), 3.66 (3H, s), 2.45 (3H, s)

REFERENCE PRODUCTION EXAMPLE 4

500 mg of 4,4′-dihydroxydiphenyl ether was dissolved in 5 ml of N,N-dimethylformamide, 200 mg of sodium hydride (60% oil suspension) was added thereto under ice-cooling, the mixture was stirred at room temperature for ten minutes. Afterward, 410 mg of 5-chloro-3-ethyl-1-methyl-1H-pyrazole-4-carboaldehyde in 5 ml of N,N-dimethylformamide was added dropwise at 70° C. under stirring over ten minutes, stirred at 70° C. for two hours. The reaction mixture was cooled to room temperature, water and 10% hydrochloric acid were added thereto, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 460 mg of the compound of formula (ii).

¹H-NMR (CDCl₃, TMS) δ (ppm): 9.51 (1H, s), 6.79-6.94 (8H, m), 5.44 (1H, s), 3.66 (3H, s), 2.86 (2H, q), 1.27 (3H, t)

REFERENCE PRODUCTION EXAMPLE 5

570 mg of 4,4′-dihydroxydiphenyl ether was dissolved in 5 ml of N,N-dimethylformamide, 170 mg of sodium hydride (60% oil suspension) was added thereto under ice-cooling, the mixture was stirred at room temperature for ten minutes. Afterward, 570 mg of 5-chloro-1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboaldehyde in 5 ml of N,N-dimethylformamide was added dropwise at 70° C. under stirring over ten minutes, stirred at 70° C. for two hours. The reaction mixture was cooled to room temperature, water and 10% hydrochloric acid were added thereto, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 440 mg of the compound of formula (vii).

1H-NMR (CDCl₃, TMS) δ (ppm): 9.66 (1H, s), 6.79-6.93 (8H, m), 4.95 (1H, s), 3.81 (3H, s)

REFERENCE PRODUCTION EXAMPLE 6

560 mg of 4,4′-dihydroxydiphenyl ether was dissolved in 10 ml of N,N-dimethylformamide, 140 mg of sodium hydride (60% oil suspension) was added thereto under ice-cooling, the mixture was stirred at 70° C. for one hour. Afterward, 400 mg of 1-(5-chloro-1,3-dimethyl-1H-pyrazo-4-yl)ethanone in 5 ml of N,N-dimethylformamide was added dropwise at 70° C. under stirring over fifteen minutes, stirred at 70° C. for six hours. The reaction mixture was cooled to room temperature, diluted hydrochloric acid was added thereto, and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over magnesium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 340 mg of the compound of formula (vi).

¹H-NMR (CDCl₃, TMS) δ (ppm): 2.26 (3H, s), 2.47 (3H, s), 3.57 (3H, s), 5.22 (1H, s), 6.79-6.95 (8H, m)

The following describes formulation examples wherein parts represent parts by weight.

FORMULATION EXAMPLE 1

10 parts of each of the present compounds (1) to (40) is dissolved in the mixture of 35 parts of xylene and 35 parts of N,N-dimethylformamide, and 14 parts of polyoxyethylene styryl phenyl ether and 6 parts of calcium dodecylbenzenesulfonate are added thereto, followed by well stirring and mixing, to give 10% emulsion for each compound.

FORMULATION EXAMPLE 2

20 parts of each of the present compounds (1) to (40) is added to a mixture containing 4 parts of sodium laurylsulfate, 2 parts of calcium lignin sulfonate, 20 parts of synthetic hydrated silicone oxide fine powder, and 54 parts of diatomaceous earth, followed by well stirring and mixing, to give 20% wettable powder for each compound.

FORMULATION EXAMPLE 3

To 2 parts of each of the present compounds (1) to (40) are added 1 part of synthetic hydrated silicon oxide fine powder, 2 parts of calcium lignin sulfonate, 30 parts of bentonite, and 65 parts of kaolin clay, followed by well stirring and mixing, and an appropriate amount of water is added to this mixture, followed by further stirring, granulation with a granulator, and air drying, to give 2% granule for each compound.

FORMULATION EXAMPLE 4

1 part of each of the present compounds (1) to (40) is dissolved in an appropriate amount of acetone, and 5 parts of synthetic hydrated silicon oxide fine powder, 0.3 part of PAP, and 93.7 parts of Fubasami clay are well stirring and mixing, and acetone is removed by evaporation from the mixture, to give 1% powder for each compound.

FORMULATION EXAMPLE 5

10 parts of each of the present compounds (1) to (40), 35 parts of white carbon containing 50 parts of polyoxyethylene alkyl ether sulfate ammonium salt, and 55 parts of water are mixed and pulverized by the wet grinding method to give 10% flowable formulation for each compound.

FORMULATION EXAMPLE 6

0.1 part of each of the present compounds (1) to (40) is dissolved in a mixture of 5 parts of xylene and 5 parts of trichloroethane, and the resulting solution is mixed with 89.9 parts of deodorized kerosine to give 0.1% oil solution for each compound.

FORMULATION EXAMPLE 7

10 mg of each of the present compounds (1) to (40) is dissolved in 0.5 ml of acetone, the solution is applied to 5 g of powdery solid animal food (powdery solid animal food for bleeding CE-2; a product of CLEA Japan, Inc.) and mixed uniformly, and acetone is removed by evaporation from the mixture, to give poison bait for each compound.

The following test example will demonstrate the noxious arthropods controlling activity of the compound of the present invention.

TEST EXAMPLE 1

Each of the present compounds (2) to (15), (17) to (33), (36) to (40) and the comparative compound described below was formulated according to Formulation Example 5, and each formulations was diluted with water so that the concentration of the present compound or the comparative compound came to 500 ppm.

About twenty female adults of Tetranychus urticae were set free on brush bean (Phaseolus vulgaris) in the primary leaf stage, which had been potted in a plastic cup for 7 days after the seeding. After 1 day, a 30 ml of the diluted formulation described-above was sprayed over the plant. On the 8th and 13th day after the application, the numbers of lived Tetranychus urticae on the leaf of brush bean plant were examined, and the Controlling Rates were calculated by the following scheme. Controlling Rate=100×{1−(a number of lived Tetranychus urticae in the treatment)/(a number of lived Tetranychus urticae in the non-treatment)}

As the result, in the treatment of the present compound (2) to (15), (17) to (33), and (36) to (40), all of the Controlling rates were not less than 90% on 8th day and 13th day after the application. In the treatment of the comparative compound, the Controlling rate was less than 30% on 8th day and 13th day after the application. Comparative Compound

which is disclosed as the Compound No. 189 in the Japan unexamined Patent Publicatition S63-183564, p.21.

TEST EXAMPLE 2

Each of the present compounds (3), (4), (6) to (10), (12) to (33), (36), (37), (39) and (40) was formulated according to Formulation Example 5, and each formulation was diluted with water so that the concentration of the present compound came to 500 ppm.

On the bottom of a polyethylene cup having a diameter of 5.5 cm, 9 g of a artificial bait (Silkmate 2S; produced by Nosan Corporation) was laid, and 1 ml of the diluted formulation described-above was added dropwise on the artificial bait. Thirty first-instar larvae of Adoxophyes orana were set free in the polyethylene cup. After 7 days, the numbers of the surviving Adoxophyes orana were examined to obtain the rate of dead pests.

As the result, in the treatment of the present compound (3), (4), (6) to (10), (12) to (33), (36), (37), (39) and (40), all of the rate of dead pests were not less than 90%.

INDUSTRIAL APPLICABILITY

By using the compound of the present invention, noxious arthropods can be controlled. 

1. A pyrazole compound of formula (a):

wherein R¹ represents C1-C4 alkyl or trifluoromethyl, R² represents C1-C4 alkyl, R³ represents hydrogen or C1-C6 alkyl; R⁴ represents halogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkyl or C1-C3 haloalkoxy, m represents 0 to 4 integer, each of R⁴s is same or different when m is 2 to 4 integer; R⁵ represents halogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkyl or C1-C3 haloalkoxy, n represents 0 to 4 integer, each of R⁵s is same or different when n is 2 to 4 integer; R⁶ and R⁷ are same or different and represents hydrogen, halogen or methyl, X represents oxygen or R⁸O—N; R⁸ represents hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyanoalkyl or benzyl (wherein the benzyl may be substituted with halogen, C1-C4 alkyl, C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro methoxy).
 2. The pyrazole compound according to claim 1, wherein R³ is hydrogen in the formula (a).
 3. The pyrazole compound according to claim 1, wherein R³ is C1-C6 alkyl in the formula (a).
 4. The pyrazole compound according to any one of claims 1 to 3, wherein X is R⁸O—N, and R⁸ is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyanoalkyl or benzyl (wherein the benzyl may be substituted with halogen, C1-C4 alkyl, C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro methoxy) in the formula (a).
 5. The pyrazole compound according to any one of claims 1 to 3, wherein X is R⁸O—N, and R⁸ is hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl or C2-C5 cyanoalkyl in the formula (a).
 6. The pyrazole compound according to any one of claims 1 to 3, wherein X is R⁸O—N, and R⁸ is a benzyl (wherein the benzyl may be substituted with halogen, C1-C4 alkyl, C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro methoxy) in the formula (a).
 7. The pyrazole compound according to any one of claims .1 to 3, wherein X is oxygen in the formula (a).
 8. The pyrazole compound according to claim 1, wherein R⁶ is halogen in the formula (a).
 9. The pyrazole compound according to claim 1, wherein R⁶ and R⁷ are halogen in the formula (a).
 10. The pyrazole compound according to claim 1, wherein R⁶ and R⁷ are chlorine in the formula (a).
 11. The pyrazole compound according to claim 1, wherein R⁴ and R⁵ are halogen, C1-C3 alkyl, C1-C3 alkoxy or trifluoromethyl, and m and n is 0 to 2 integer in the formula (a).
 12. A noxious arthropods controlling composition comprising an effective amount of the pyrazole compound according to claim
 1. 13. A method for controlling noxious arthropods comprising applying an effective amount of the pyrazole compound according to claim 1 to noxious arthropods or habitat of noxious arthropods.
 14. Use of the pyrazole compound according to claim 1 as an active ingredient of a noxious arthropods controlling composition.
 15. A compound of formula (b):

wherein R¹ represents C1-C4 alkyl or trifluoromethyl, R² represents C1-C4 alkyl, R³ represents hydrogen or C1-C6 alkyl; R⁴ represents halogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkyl or C1-C3 haloalkoxy, m represents 0 to 4 integer, each of R⁴s is same or different when m is 2 to 4 integer; R⁵ represents halogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C3 haloalkyl or C1-C3 haloalkoxy, n represents 0 to 4 integer, each of R⁵s is same or different when n is 2 to 4 integer; X represents oxygen or R⁸O—N; R⁸ represents hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C2-C5 cyano alkyl or benzyl (wherein the benzyl may be substituted with halogen, C1-C4 alkyl, C1-C4 alkoxy, C2-C5 alkoxycarbonyl, trifluoromethyl or trifluoro methoxy). 